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The clearance of damaged or dysfunctional mitochondria by selective autophagy (mitophagy) 
is important for cellular homeostasis and prevention of disease. Our understanding of the 
mitochondrial signals that trigger their recognition and targeting by mitophagy is limited. Here 
we show that the mitochondrial matrix proteins NIPSNAP1 (4-Nitrophenylphosphatase 
domain and non-neuronal SNAP25-like protein homolog 1) and NIPSNAP2 accumulate on the 
mitochondria surface upon mitochondrial depolarization. There they recruit proteins involved 
in selective autophagy, including autophagy receptors and ATG8 proteins, thereby functioning 
as an “eat-me signal” for mitophagy. NIPSNAP1 and NIPSNAP2 have a redundant function in 
mitophagy and are predominantly expressed in different tissues, with NIPSNAP1 being the 
most abundant in the brain. Zebrafish lacking a functional Nipsnap1 display reduced mitophagy 
in the brain and parkinsonian phenotypes, including loss of tyrosine hydroxylase (Th1) positive 







Macroautophagy (hereafter autophagy) is an intracellular pathway that involves  sequestration 
of cytoplasmic cargo into autophagosomes that fuse with the lysosome for degradation (Lamb 
et al., 2013). Autophagy is needed for survival upon cellular stress, such as starvation and 
hypoxia, but also has an important housekeeping function by selective removal of damaged or 
dysfunctional cellular components. Selective autophagy involves specific autophagy receptors 
that can recognize ligands (e.g. ubiquitin) on the cargo to become degraded (Rogov et al., 2014; 
Stolz et al., 2014). Several ubiquitin-binding autophagy receptors have been identified. 
Typically, one given autophagy receptor is involved in different types of selective autophagy. 
Similarly, a given type of selective autophagy may require more than one autophagy receptor 
(Lazarou et al., 2015). Sequestosome-1 (SQSTM1)/p62 is the best-studied autophagy receptor 
and has been implicated in selective degradation of many types of ubiquitinated cargos, 
including aggregate-prone proteins (Bjorkoy et al., 2005), mitochondria (Geisler et al., 2010; 
Zhong et al., 2016), bacteria (Zheng et al., 2009) and midbody remnants (Isakson et al., 2013; 
Pohl and Jentsch, 2009). Autophagy receptors interact with microtubule associated protein 1 
light chain 3 (LC3) and/or GABA type A receptor-associated protein (GABARAP) family 
proteins through a specific LC3-interacting region (LIR) (Birgisdottir et al., 2013; Pankiv et 
al., 2007). The concomitant binding of autophagy receptors to cargo and LC3/GABARAP 
proteins in the autophagy membrane targets cargo for degradation. Selective autophagy may 
also require autophagy adaptor proteins, which possess a LIR, but are themselves not degraded 
by autophagy (Stolz et al., 2014). ALFY (autophagy-linked FYVE) is a large scaffolding 
protein that functions as an autophagy adaptor protein by binding to GABARAP and 
phosphatidyl-inositol 3-phosphate (PtdIns3P) in the autophagy membrane (Lystad et al., 2014; 
Simonsen et al., 2004). ALFY also interacts with the autophagy receptors p62 and neighbor of 
BRCA1 gene 1 (NBR1) (Clausen et al., 2010; Isakson et al., 2013) and is important for selective 
clearance of protein aggregates (Filimonenko et al., 2010; Lystad et al., 2014), midbody 
remnants (Isakson et al., 2013) and viral particles (Mandell et al., 2014).  
Turnover of damaged and dysfunctional mitochondria through mitophagy is important 
for cellular homeostasis, particularly in post-mitotic and slow dividing cells, such as neurons 
and cardiomyocytes. Causative mutations in two proteins involved in mitophagy, the E3 
ubiquitin ligase PARKIN and the kinase PTEN-induced putative kinase 1 (PINK1), are linked 
to Parkinson’s disease (PD) (Pickrell and Youle, 2015). PINK1 is stabilized on the outer 
mitochondrial membrane after loss of mitochondrial membrane potential, where it 
phosphorylates ubiquitin (Kane et al., 2014; Kazlauskaite et al., 2014; Koyano et al., 2014) and 
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PARKIN (Kondapalli et al., 2012), leading to PARKIN activation and further K63-linked poly-
ubiquitination of mitochondrial substrate(s). This is followed by recruitment of autophagy 
receptors, including optineurin 1 (OPTN1) and nuclear dot protein 52 (NDP52) (Lazarou et 
al., 2015). While p62 and NBR1 seem dispensable for PARKIN-dependent mitophagy in HeLa 
cells (Lazarou et al., 2015), p62 is essential for PARKIN-dependent mitophagy in macrophages 
treated with inflammasome NLRP3 agonists (Zhong et al., 2016), suggesting cell- or context-
specific variations in employment of autophagy receptors in mitophagy. Recently, the inner 
mitochondrial membrane protein, prohibitin 2 (PHB2) was found to bind LC3 upon 
mitochondria outer membrane rupture and function as a receptor for PARKIN-induced 
mitophagy (Wei et al., 2017). Our knowledge about the mitochondrial signals that trigger 
mitophagy and recruitment of autophagy receptors is however still limited. In this study we 
identify the mitochondrial matrix proteins NIPSNAP1 and NIPSNAP2 as “eat-me signals” for 
damaged mitochondria through their recruitment of proteins involved in selective autophagy 
and show that NIPSNAP1 and -2 have redundant roles in PARKIN-dependent mitophagy and 




NIPSNAP1 and NIPSNAP2 interact with hATG8 proteins, ALFY and autophagy 
receptors 
To identify new ALFY and/or p62 interacting proteins, cell lysates from ALFY+/+ and ALFY-
/- mouse embryonic fibroblasts (MEFs) (Dragich et al., 2016) or HEK293 cells stably 
expressing EGFP-p62 were immunoprecipitated with an anti-ALFY antibody or GFP-TRAP, 
respectively, followed by mass spectrometry analysis of the precipitates. Interestingly, the two 
homologous proteins NIPSNAP1 and NIPSNAP2 (also called GBAS) were identified as 
unique interactors of both ALFY and p62 (Figures 1A and 1B). 
 NIPSNAP1 and NIPSNAP2 are members of the NIPSNAP-domain protein family 
containing four highly conserved proteins in humans (the other two are NIPSNAP3A and 
NIPSNAP3B) (Figure S1A). They both contain a putative mitochondrial targeting signal 
(MTS) in the N-terminus, followed by two dimeric alpha-beta-barrel (DABB) domains, the 
second of which is also referred to as a NIPSNAP domain (Figure S1B). Interestingly, the 
expression of NIPSNAP1 and -2 in mice was limited to a few organs rich in mitochondria and 
was only partially overlapping (Figure 1C). NIPSNAP1 is almost exclusively expressed in the 
brain, kidney and liver, while NIPSNAP2 is most expressed in the heart, but also expressed in 
5 
 
brain, kidney, liver, muscle and brown adipose tissue. This is in line with the human mRNA 
levels of NIPSNAP1 and NIPSNAP2 (gtexportal.org), suggesting these proteins may have 
similar functions in different tissues.  
As expected from our proteomics data, endogenous ALFY and p62 interacted with 
NIPSNAP1-EGFP in U2OS cells transiently transfected with NIPSNAP1-EGFP (Figure 1D). 
ALFY and p62 are known to interact with each other (Clausen et al., 2010), but their 
interactions with NIPSNAP1 occurred independently, as GFP-pulldown after depletion of 
either transcript (Figure 1D) or in the respective knock-out (KO) MEFs (Figure S1C) did not 
impact interaction of NIPSNAP1-EGFP with the other protein. Interestingly, several other 
autophagy receptors were found to co-purify with NIPSNAP1- and NIPSNAP2-MYC stably 
expressed in HeLa cells, including NBR1, NDP52 and TAX1BP1 (Figure S1D). Direct 
interactions between p62, NBR1, NDP52 and TAX1BP1 with NIPSNAP1 or -2 were 
confirmed by GST pulldown assays of in vitro translated proteins (Figures 1E and S1E).  
 NIPSNAP1 and -2 were previously identified as binding partners of LC3 and 
GABARAP proteins (Behrends et al., 2010; Rigbolt et al., 2014). In line with this, both 
endogenous NIPSNAP1 and in vitro translated NIPSNAP1 and -2 interacted with all human 
LC3 and GABARAP proteins when overexpressed as EGFP-tagged proteins in HeLa cells 
(Figure S1F) or expressed as recombinant GST-tagged proteins (Figure 1F), respectively. 
Taken together, we have identified NIPSNAP1 and -2 as binding partners of proteins involved 
in selective autophagy, including the autophagy receptors p62, NBR1, NDP52 and TAX1BP1, 
ALFY and human ATG8 family proteins.  
 
NIPSNAP1 and NIPSNAP2 are mitochondrial proteins 
In line with the previous identification of NIPSNAP1 as a mitochondrial protein in rat liver 
(Nautiyal et al., 2010), human NIPSNAP1- and NIPSNAP2-EGFP co-localized extensively 
with mitochondrial markers when expressed in U2OS or HeLa cells (Figures S2A and S2B). 
NIPSNAP1 also co-purified with the mitochondrial matrix protein pyruvate dehydrogenase 
(PDH) and translocase of outer mitochondrial membrane 20 (TOMM20) in the mitochondrial 
fraction (Figure 2A). Proteinase K (PK) treatment of the mitochondrial fraction showed 
protection of NIPSNAP1 and -2 even in the presence of osmotic shock, similar to PDH, but in 
contrast to TOMM20 and translocase of inner mitochondrial membrane 23 (TIMM23) 
(Figures 2B and S2C). Similarly, PK treatment in the presence of increasing amounts of 
digitonin to perforate the mitochondrial membranes, showed partial protection of NIPSNAP1 
and -2 along with the mitochondrial matrix protein superoxide dismutase 2 (SOD2), while 
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TOMM20 and TIMM23 were degraded at the lowest concentration of digitonin (Figure S2D). 
The protected NIPSNAP1/2 bands migrated faster upon SDS-PAGE than the full-length 
proteins, suggesting that an exposed part of the protein is efficiently cleaved off by PK. 
Mitochondrial NIPSNAP1 remained extractable by alkaline Na2CO3, indicating its lack of 
integration into the mitochondria membrane (Figure 2C). Taken together our data indicate that 
NIPSNAP1 and -2 are intra-mitochondrial proteins.  
 
NIPSNAP1 contains two mitochondrial targeting signals 
Overexpression in HeLa cells (Figure 2D) and an in vitro mitochondrial import assay (Figure 
2E), revealed that NIPSNAP1 is efficiently imported into mitochondria. Fusion of the N-
terminal 20- or 19 amino acids of NIPSNAP1 or -2 to EGFP effectively targeted EGFP inside 
the mitochondria, while deletion of the N-terminal 58 amino acids abolished localization of 
both NIPSNAP1-EGFP and NIPSNAP2-EGFP to mitochondria (Figure 2D). Hence, the N-
terminal parts of NIPSNAP1 and -2 are both sufficient and essential for intra-mitochondrial 
localization. Interestingly, while NIPSNAP1 and -2 lacking the first 23 or 21 amino acids, 
respectively were not imported into mitochondria, they were recruited to the mitochondrial 
surface (Figures 2F and S2F) and remained sensitive to PK degradation (Figure 2E). A 
NIPSNAP1 deletion construct containing only the region between amino acids 24 and 64 
(NIPSNAP1(24-64)-EGFP) was sufficient to localize EGFP to the mitochondrial surface 
(Figure 2F), indicating this region contains an internal MTS. In line with this, when full-length 
NIPSNAP1-mCherry was expressed together with NIPSNAP1(24-284)-EGFP the two proteins 
showed distinct mitochondrial localization, also indicating that accumulation on the 
mitochondrial surface was not an overexpression artefact (Figures 2G and S2E). Together, our 
data show that the N-termini of NIPSNAP1 and -2 contain two signals for recruitment, 
tethering and import into mitochondria. NIPSNAP3A and –B, on the other hand, both contain 
a MTS but no signal for tethering to the mitochondria (Figure S2F).   
 
NIPSNAP1 localizes to the mitochondrial surface upon membrane depolarization 
Since we identified NIPSNAP1 and -2 as binding partners of autophagy-related proteins, we 
assumed that NIPSNAP1 and -2 in direct contact with the cytosol would engage in such 
interactions upon induction of mitophagy. In line with such a model, EGFP-tagged NIPSNAP1 
accumulated on the surface of mitochondria upon disruption of the mitochondrial membrane 
potential with Carbonyl cyanide m-chlorophenyl hydrazine (CCCP) (Figure S3A), suggesting 
that NIPSNAP1 and -2 are exposed to the cytosol upon mitochondrial damage. As EGFP can 
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be cleaved off from NIPSNAP1 (Figure S3B) and fill up the mitochondrial matrix, making it 
difficult to distinguish surface-bound from matrix-localized NIPSNAP1 and free EGFP, we 
employed several imaging and biochemical approaches to investigate whether surface localized 
NIPSNAP1 and -2 represent proteins re-exported from the mitochondrial matrix and/or newly 
synthesized proteins that are not imported. First we transfected U2OS cells with NIPSNAP1 
fused to a small 3XFLAG tag. As expected, NIPSNAP1-3XFLAG co-localized extensively 
with Mitotracker Red and TIMM23 (Figures 3A and S3C). Interestingly, NIPSNAP1-
3XFLAG also surrounded these mitochondrial markers in approximately 15% of the untreated 
cells (Figures 3A and S3C, lower panel). The number of cells with the latter phenotype 
increased to approximately 30% upon CCCP treatment (Figure 3A). As an alternative 
approach, cells were transfected to express NIPSNAP1-EGFP-CIB1 fusion protein together 
with the cytosolic CRY2low-tdTomato (Figure 3B). Exposure of the cells to blue light causes 
formation of transient (time frame of minutes) complexes between CIB1 and CRY2low (Duan 
et al., 2017), effectively labeling NIPSNAP1 with tdTomato. Using this approach, we observed 
recruitment of tdTomato signal to mitochondria, indicating that a fraction of NIPSNAP1-
EGFP-CIB1 is bound to the surface of mitochondria (Figure 3B). To further corroborate these 
findings and control the mitochondrial targeting of NIPSNAP1, we exploited the ability of 
globular proteins to block mitochondrial import when fused N-terminally to a MTS. Using 
HeLa cells stably expressing a SUMOstar-NIPSNAP1-EGFP fusion protein and a tet-regulated 
SUMOstar protease allows inducible cleavage of the peptide bond between the SUMOstar tag 
and the fused protein by the mutant SUMOstar protease (Figure 3C). While these cells showed 
diffuse cytosolic EGFP-staining without tet-induction, mitochondrial EGFP-staining and 
cleavage was observed upon tet-mediated induction of the SUMOstar protease (Figure S3D 
and S3E), showing that the SUMOstar tag prevents mitochondrial import of NIPSNAP1. 
Interestingly, a combination of SUMOStar protease induction and CCCP treatment caused 
accumulation of NIPSNAP1 on the mitochondrial surface (Figure 3C).  
Outer mitochondrial membrane (OMM) proteins fused to a 3xHA tag has recently been 
used for rapid immunopurification of mitochondria (Chen et al., 2016). Interestingly, increased 
amounts of mitochondria were purified with anti-HA magnetic beads from cells stably 
expressing 3xHA-tagged NIPSNAP1 than from cells expressing 3xFLAG-tagged NIPSNAP1 
or the mitochondrial matrix protein PDH tagged with 3xHA (Figure 3D). In line with our 
imaging data, more mitochondria were immunopurified from NIPSNAP1-EGFP-3xHA cells 
treated with CCCP (Figure 3D), showing that the fraction of NIPSNAP1 found on the 
mitochondrial surface increases upon disruption of the mitochondrial membrane potential. 
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 Consistent with the model that a fraction of NIPSNAP1 accumulate on the OMM 
following depolarization, alkaline sodium carbonate (Na2CO3) extraction of isolated 
mitochondria showed that NIPSNAP1 was extracted into the supernatant in untreated cells, but 
was partly retained in the pellet in cells treated with a combination of Oligomycin and 
Antimycin A (OA) or CCCP (Figure 3E). Moreover, NIPSNAP1 and -2 found in the pellet 
fractions upon Na2CO3 extraction of OA treated cells were highly sensitive to PK treatment, 
demonstrating their OMM association (Figure 3F). This suggests that NIPSNAP1 and -2 are 
not imported into the matrix, but associate firmly with the mitochondrial membrane surface 
upon loss of the membrane potential. This is in contrast to cytochrome C oxidase subunit II 
(COXII) in the inner mitochondrial membrane (Figure 3F). Furthermore, while in vitro-
translated NIPSNAP1 was partially protected from PK when added to untreated mitochondria 
in an in vitro mitochondrial import assay, it was not protected from PK when added to 
mitochondria treated with Carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP), 
although there was no difference in the binding to isolated mitochondria in the absence or 
presence of FCCP (Figure 3G). Hence, a functional membrane potential is important for 
mitochondrial import of NIPSNAP1, but not for its binding to mitochondria. 
 
NIPSNAP1 and NIPSNAP2 act as “eat-me” signals for mitophagy of damaged 
mitochondria  
As NIPSNAP1 localized to the mitochondrial surface upon membrane depolarization and 
interacted with proteins involved in selective autophagy, we speculated that it could function 
as an “eat-me” signal for degradation of depolarized mitochondria by autophagy. Indeed, the 
interaction of NIPSNAP1 and -2 with the autophagy receptors p62 and NDP52 increased in 
cells treated with CCCP or hypoxic conditions as compared to untreated cells, as analyzed by 
immunoprecipitation (Figures 4A-E and S3F) and proximity-labeling (Figure S3G). 
Moreover, a NIPSNAP1-GABARAP complex accumulated on the surface of mitochondria 
upon CCCP treatment, as assessed by a split-YFP bimolecular fluorescence complementation 
assay (Nyfeler et al., 2008), while there was little or no mitochondrial YFP signal in untreated 
or control cells (Figures 4F and S3H). LC3B and ALFY were also recruited to mitochondria 
in a CCCP-dependent manner and detected on NIPSNAP1-positive structures (Figure 4G). 
Taken together, our data show that mitochondrial depolarization tethers NIPSNAP1 and -2 to 
the mitochondrial surface, where NIPSNAP1 and -2 recruit proteins involved in selective 




NIPSNAP1 and NIPSNAP2 have redundant functions in mitophagy 
To further investigate a possible role of NIPSNAP1 and -2 in mitophagy, HeLa cells stably 
expressing PARKIN were subjected to siRNA-mediated depletion of NIPSNAP1 and/or -2, 
followed by treatment with CCCP or OA for 12 h or 24 h. siRNA-mediated depletion of ATG7 
was used as a control (Figure S4A). Mitophagy was measured by analyzing the levels of the 
inner membrane proteins COXII and TIMM23. COXII is ideally suited as a marker since it is 
encoded by the mitochondrial genome and not imported. Depletion of NIPSNAP1, either alone 
or together with NIPSNAP2, inhibited both CCCP- and OA- induced degradation of COXII 
and TIMM23 as analyzed by immunoblotting for COXII and TIMM23 (Figures S4B,C and F-
H) and immunostaining for TIMM23 (Figures S4D,E). In contrast, depletion of NIPSNAP2 
alone had no effect on CCCP/OA-induced mitophagy. However, using two independent 
siRNAs against NIPSNAP1, we noticed that its depletion also reduced NIPSNAP2 levels 
(Figure S4I). Thus, to further evaluate their individual contribution to PARKIN-dependent 
mitophagy, we employed CRISPR technology to deplete either NIPSNAP1 or -2 or both in 
HeLa cells, using ATG7 as a control (Figures 5A and S4J). These cells were then transfected 
to stably express mCherry-PARKIN and analyzed for CCCP- or OA-induced mitophagy. As 
anticipated from the siRNA experiments, single NIPSNAP1 or -2 KO had no effect on OA-
induced PARKIN-dependent mitophagy, as measured by degradation of COXII in two 
different clones of each, although this was strongly inhibited in the ATG7 KO cells (Figures 
S4J-L). However, similar to the NIPSNAP1 siRNA acting on both NIPSNAP1 and -2, double 
knockout of both NIPSNAP1 and -2 (N1/N2 DKO) blocked both CCCP- and OA-induced 
mitophagy. This was measured by immunoblotting of COXII (Figures 5B-C and S5A) and 
immunostaining of mitochondrial DNA nucleoids (Figures 5D, E). Additionally, expression 
of the mCherry-EGFP-OMP25TM tandem tag mitophagy reporter confirmed that red only dots 
formed in WT cells, but not in N1/N2 DKO cells or ATG7 KO cells upon OA- or CCCP 
treatment (Figures 5F and S5B). Importantly, re-expression of either NIPSNAP1 or -2 in DKO 
cells revealed that they function redundantly, as both were able to rescue CCCP- or OA-
induced mitophagy independently (Figures 5G-J and S5C). Importantly, over-expression of 
either NIPSNAP1 or -2 in HeLa PARKIN cells did not give an increase in CCCP or OA-
induced mitophagy (Figures S6A, B). Taken together, our data show that NIPSNAP1 and -2 
are required for PARKIN-dependent mitophagy and have a redundant function.  
Interestingly, depletion of NIPSNAP1 and/or -2 did not inhibit PARKIN-independent 
mitophagy induced by the iron-chelator deferiprone (DFP) in U2OS cells expressing another 
tandem-tag mitophagy reporter (NIPSNAP (1-53)-GFP-mCherry), although siRNA-mediated 
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depletion of ULK1 or addition of the lysosomal proton pump inhibitor Bafilomycin A1 
(BafA1) efficiently blocked DFP-induced mitophagy (Figures S5D-F). Depletion of 
NIPSNAP1 or -2 had no effect on the oxygen consumption rate of the mitochondria (Figure 
S5G) or on basal macro-autophagy as measured by degradation of long-lived proteins upon 
starvation (Figure S5H) or mitochondria membrane depolarization (Figure S5I). Similarly, 
knockout of both NIPSNAP1 and -2 did not affect macro-autophagic degradation of 
p62/SQSTM1 and NDP52/CALCOCO2 under basal or starved conditions (Figures S6C, D), 
suggesting a specific role for NIPSNAP1 and -2 in PARKIN-dependent mitophagy.  This is 
supported by our finding of an interaction between NIPSNAP1 and PARKIN in U2OS cells 
(Figure S5J).   
 
NIPSNAP1 and NIPSNAP2 recruit autophagy receptors to mediate mitophagy 
To determine if localization of NIPSNAP1 and -2 on the surface of mitochondria is responsible 
for their function in mitophagy, NIPSNAP2 lacking the MTS (NIPSNAP2 1-24) was stably 
expressed in N1/N2 DKO cells. Treatment with OA or CCCP showed that NIPSNAP2 1-24, 
which binds to the mitochondria surface but is not imported, was able to rescue both OA- and 
CCCP-induced PARKIN-dependent mitophagy in a comparable manner to the full-length 
protein (Figures 6A,B and S6E), indicating an important function of NIPSNAPs on the 
mitochondria surface in mitophagy. 
Interestingly, following treatment with either OA or CCCP, we noticed that no mtDNA 
nucleoid aggregation or clustering was observed in N1/N2 DKO cells compared to WT or 
ATG7 KO cells (Figures 5D, F and I), a role attributed to p62/SQSTM1 (Okatsu et al., 2010). 
We therefore speculated that NIPSNAP1 and -2 may be required for recruitment of autophagy 
receptors to the mitochondria following depolarization. To test this, WT and N1/N2 DKO cells 
stably expressing mCherry-PARKIN were treated with CCCP in the absence or presence of the 
proteasome inhibitor MG132 for three hours, followed by fractionation of mitochondria and 
immunoblotting for autophagy receptors. Interestingly, PARKIN recruitment and 
ubiquitination of mitochondria were similar in WT and N1/N2 DKO cells (Figure 6C). 
However, recruitment of the autophagy receptors NDP52, p62, OPTINEURIN and TAX1BP1 
to mitochondria in N1/N2 DKO cells was dramatically reduced compared to WT cells (Figure 
6C). Taken together, our data show that whereas PARKIN recruitment and ubiquitination of 
OMM proteins occur both in WT and DKO cells, NIPSNAP1/2 are required for recruitment of 
autophagy receptors during mitophagy.  
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While PINK1 is rapidly degraded under normal conditions, it accumulates on the outer 
mitochondrial membrane following mitochondrial depolarization, where it phosphorylates 
both ubiquitin and PARKIN on Ser65 to initiate mitochondrial clearance (Kane et al., 2014; 
Kazlauskaite et al., 2014; Kondapalli et al., 2012; Koyano et al., 2014). To test if PINK1 and/or 
PARKIN contribute to accumulation of NIPSNAP1 and -2 on the outer membrane following 
mitochondrial depolarization, we first examined if NIPSNAP1 and -2 are phosphorylated upon 
mitochondrial depolarization. Using Phos-tag SDS-PAGE, we observed similar 
phosphorylation levels of NIPSNAP1 and -2 with and without CCCP-treatment (Figure S6F). 
Consistently, no phosphorylation of NIPSNAP1 or -2 by PINK1 was detected, whereas 
PARKIN and ubiquitin were both phosphorylated by PINK in vitro (Figure S6G). Secondly, 
while MFN2 was ubiquitinated by PARKIN upon CCCP treatment, in agreement with (Sarraf 
et al., 2013), we did not observe any increase in ubiquitination of NIPSNAP1 and -2, either by 
immunoprecipitation of the endogenous or over-expressed proteins (Figures S6H, I). 
By deletion mapping using GST-pulldown assays, we found that both p62 and NDP52 
bind to the region encompassing amino acids 65-100 of NIPSNAP1 and -2 (Figures S6J, K). 
For NDP52 the C-terminal zinc-finger domain (amino acid 343-446) is sufficient for binding 
to both NIPSNAPs (Figure S6L). Interestingly, this domain is also required for binding of 
NDP52 to ubiquitin, myosin VI and galectin 8 (Thurston et al., 2012; Tumbarello et al., 2012). 
NDP52 has two Zinc finger domains (ZF1 and ZF2) and it was found that only the most C-
terminal zinc finger domain is required for binding to ubiquitin (Xie et al., 2015). Since 
ubiquitin plays a major role in PINK1-PARKIN-mediated mitophagy we asked whether 
interaction of NIPSNAP1/2 with NDP52 was ubiquitin-dependent. Remarkably, although 
binding of NDP52 to both NIPSNAP1, -2 and ubiquitin required the ZF2 domain, several 
mutations that abolished binding to ubiquitin did not affect binding to NIPSNAP1 or -2 
(Figures 6D-E), suggesting that binding of NDP52 to NIPSNAP1 and -2 and ubiquitin can 
occur simultaneously. To examine how NDP52 is recruited to mitochondria, NDP52 KO cells 
were transfected with mCherry-Parkin together with NDP52 WT, a ZF2 point mutant (L446A) 
that cannot bind ubiquitin, but interacts with NIPSNAP1 and -2, or a deletion mutant (1-414) 
lacking the ZF2 domain and neither interacts with NIPSNAP1 and -2 nor ubiquitin. Treatment 
with CCCP for 6h revealed that both WT NDP52 and the L446A mutant were recruited to the 
mitochondria, while NDP52 1-414 remained cytosolic (Figures 6F and S6M). The NDP52 
L446A mutant is mostly recruited to fragmented mitochondria and not to perinuclear 
mitochondrial clusters. These result suggest that initial recruitment of NDP52 to damaged 
mitochondria is very likely mediated by ubiquitination of OMM proteins. However, the 
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subsequent and sustained mitophagy-dependent recruitment of NDP52 is dependent on 
NIPSNAP1 and/or -2 (Figure 6C). 
 
NIPSNAPs are evolutionary conserved and expressed during zebrafish embryogenesis 
To elucidate a function for NIPSNAPs in vivo we used zebrafish as a model organism. 
Zebrafish Nipsnap1 and -2 display high amino acid identity (≥ 75%) to the human and mouse 
proteins, indicating evolutionary conservation (Figures S7A, B). The temporal expression 
pattern of nipsnap1 and nipsnap2 during zebrafish embryogenesis as determined by 
quantitative PCR (qPCR) showed maternal expression, evident from 2 cells to 2 h post 
fertilization (hpf), which for nipsnap1 gradually increased throughout gastrulation, peaking at 
9 hpf, followed by a decrease down to 3 days post fertilization (dpf) and thereafter remained 
low. In contrast, nipsnap2 expression was lower than nipsnap1 during gastrulation and 
increased from 3 dpf (Figure S7C).  
Whole-mount mRNA in situ hybridization (WISH) revealed nipsnap1 as ubiquitously 
expressed from very early stages of embryogenesis, present in the endoderm by the 6-somites 
stage (11.5 hpf) with even stronger staining at 1 dpf (Figure 7A). In line with this, nipsnap1 
mRNA was detected in endoderm-derived organs such as the liver, intestine and pectoral fins 
and was predominantly expressed in the head from 1-4 dpf. Consistent with the pPCR results 
the expression of nipsnap1 decreased considerably at 5 dpf, nipsnap2 was also expressed in the 
brain during development, but in contrast to nipsnap1 showed expression in the myotome at 1 
dpf (Figure S7D). Western blot analysis of Nipsnap1 and Nipsnap2 in different zebrafish adult 
tissues showed that Nipsnap1 was the predominant form expressed in the brain, heart, muscle, 
liver, intestine, testis, ovary and in low amounts in kidney, whereas Nipsnap2 was found in 
brain, heart, testis and highly expressed in the ovary (Figure S7E). As tissue-specific 
expression of Nipsnap1 and Nipsnap2 was also seen in mouse and human tissues (Figure 1C 
and gtexportal.org) and these proteins have a redundant function in mitophagy in cellular 
models where they are both abundant, we decided to focus our further in vivo investigation on 
Nipsnap1.   
 
Mitophagy is reduced in Nipsnap1 deficient zebrafish larvae  
We used CRISPR/Cas9-mediated genome editing of nipsnap1 in zebrafish embryos to achieve 
near complete depletion of Nipsnap1 protein (Figures 7G and S7F). Nipsnap1 KO larvae 
(nipsnap1-/-) did not survive beyond day five and were highly dorsalized with larger heads, eye 
defects and prominent pericardial edema. We also procured a zebrafish line carrying the 
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heterozygous nipsnap1sa14357 mutant allele from the Zebrafish Mutation Project (ZMP) 
(Kettleborough et al., 2013), having a single T > A base pair change in exon 6 (Figure S7F) 
resulting in an in-frame, premature stop codon. Immunoblotting of lysates from Nipsnapsa14357 
embryos (nipsnap mutant) at 72 hpf showed a significant reduction of the Nipsnap1 protein 
compared to wild type (WT) with no smaller molecular weight bands appearing, suggesting 
that the shorter transcripts undergo nonsense-mediated decay (Figure 7G).  
To investigate whether Nipsnap1 deficient larvae display reduced mitophagy, we 
generated stable transgenic zebrafish lines expressing zebrafish COXVIII-GFP-mCherry 
(Figure 7B) in the control (WT) or nipsnap1 mutant background, based on the tandem-tag 
principle where mitochondria in lysosomes are visualized as red only structures (due to pH-
sensitive quenching of GFP). The ratio of red to yellow puncta was significantly reduced in the 
head region of Nipsnap1 deficient larvae at 3 dpf (Figures 7B, C), although large variation 
between different cell types could be detected. Interestingly, there was no difference in red dot 
formation in the muscle of WT and Nipsnap1 deficient larva (not shown), in line with Nipsnap2 
being abundantly expressed in muscles (Figure S7D), suggesting it could facilitate mitophagy 
in this tissue. Importantly, the decreased level of mitophagy in the head of nipsnap1 mutants 
could be partially rescued by the injection of zebrafish wild-type nipsnap1 mRNA into 1 cell 
nipsnap1 mutant embryos (Figures 7B,C and S7G), further demonstrating the importance of 
Nipsnap1 for efficient mitophagy in the brain of zebrafish larvae.  
 
Nipsnap1 deficient zebrafish larvae display parkinsonism 
PD is characterized by death of dopaminergic (DA) neurons in the substantia nigra, which can 
be linked to dysfunctional mitophagy and increased level of Reactive Oxygen Species (ROS) 
in these cells (Pickrell and Youle, 2015). As Nipsnap1 was mainly detected in the brain of 
zebrafish larvae (Figure 7A), and mouse (Figure 1C), consistent with its reported high 
expression in DA neurons in midbrain and noradrenergic neurons in the brainstem of mice 
(Nautiyal et al., 2010), we asked if Nipsnap1 deficient larva displayed parkinsonian 
phenotypes. Indeed, a significant increased level of ROS was seen in the nipsnap1 mutant and 
nipsnap1-/- embryos compared to WT controls (Figures 7D and S7H). We next asked if the 
high levels of ROS seen in Nipsnap1 deficient larvae would affect DA neuronal health. 
Tyrosine hydroxylase (Th) catalyzes conversion of L-tyrosine to L-DOPA, the precursor for 
dopamine, and is the rate-limiting enzyme in dopamine synthesis. Zebrafish have two orthologs 
of Th (Th1 and Th2), where the level of neuronal Th1 can be used to infer DA neuron health 
(Holzschuh et al., 2001). Interestingly, both nipsnap1 mutant and nipsnap1-/- embryos showed 
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a dramatic reduction in th1 staining compared to controls as analyzed by WISH (Figures 7E, 
F) and immunoblotting for Th1 (Figures 7G and S7I), indicating increased death of DA 
neurons and possibly lower levels of dopamine. Indeed, TUNEL (Terminal deoxynucleotidyl 
transferase dUTP Nick End Labeling) staining showed increased cell death in the head of 
nipsnap1 mutants compared to the WT controls (Figures 7H, I). The conserved dopaminergic 
diencephalospinal tract (DDT) mediates the vertebrate locomotor development and activity 
(Lambert et al., 2012) and we therefore asked whether locomotor activity was different in 
nipsnap1 mutant larvae at 7 dpf compared to WT larvae. Indeed, the swimming activity of 
nipsnap1 mutants was dramatically reduced compared to WT larvae, both in the light and the 
dark over the time course of the Zebrabox experiment (Figure 7J). Most interestingly, the 
swimming defect of nipsnap1 mutants was rescued with exogenous addition of 5 mM L-DOPA 
(Figures 7J and S7J), indicating that locomotion defect of nipsnap1 mutants is due to the 
reduced number of dopaminergic neurons in the mutants (Figures 7E-G).  
 
Discussion 
The mitochondrial matrix proteins NIPSNAP1 and NIPSNAP2 have a redundant function 
in PARKIN-mediated mitophagy   
Several mitochondrial insults such as high ROS levels, hypoxia, chemical stress and 
mutations in mitochondrial genes induce mitophagy. Much effort has been put into 
deciphering mechanisms of recognition of damaged mitochondria. Here we identified 
NIPSNAP1 and NIPSNAP2 as binding partners of the autophagy receptor p62 and its 
interacting protein ALFY, both involved in selective autophagy (Rogov et al., 2014; Stolz et 
al., 2014). We found that NIPSNAP1 and -2 are predominantly mitochondrial matrix proteins. 
However, they also localize to the OMM upon CCCP- or OA-induced mitochondrial 
depolarization. We show that NIPSNAP1 and -2 are required for mitochondrial recruitment of 
several autophagy receptors and ATG8 homologs and have a redundant function in PARKIN-
dependent mitophagy acting as “eat-me” signals for mitophagy.  
A mitochondrial membrane potential is required for import of most mitochondrial 
proteins (Kulawiak et al., 2013; Truscott et al., 2003). Such proteins generally do not decorate 
the OMM upon treatment with CCCP. In contrast, NIPSNAP1 is readily detected on the surface 
of depolarized mitochondria and is also found on the mitochondria surface in non-treated cells. 
Using a range of different in vitro and in vivo approaches, we demonstrate that cytosolic 
NIPSNAP1 accumulates on mitochondrial surface upon depolarization. The possibility that 
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intra-mitochondrial NIPSNAP1 and -2 become stabilized at the surface cannot be completely 
excluded.  
Although mitophagy in general depends on autophagy receptors, it is not entirely clear 
why only some of the autophagy receptors are important for mitophagy in certain cell lines. 
PARKIN-dependent mitophagy relies on several autophagy receptors (Lazarou et al., 2015; 
Zhong et al., 2016). Only NDP52, TAX1BP1 and OPTINEURIN have been shown to be 
necessary for PARKIN-dependent mitophagy in HeLa cells (Lazarou et al., 2015), while p62 
is sufficient for PARKIN-dependent mitophagy in macrophages (Zhong et al., 2016). The 
autophagy receptors NDP52, NBR1, OPTINEURIN, p62 and TAX1BP1 all have ubiquitin 
binding domains (Birgisdottir et al., 2013) and p62 and OPTINEURIN have been shown to 
bind to damaged mitochondria in a PARKIN and ubiquitin-dependent manner (Okatsu et al., 
2010). PARKIN-mediated ubiquitination of mitochondrial proteins cannot fully account for 
these differences. Recently, the inner mitochondrial membrane protein, prohibitin 2 (PHB2) 
was found to bind LC3 upon mitochondrial depolarization and function as a receptor for 
PARKIN-induced mitophagy (Wei et al., 2017). Here we demonstrate that recruitment of 
autophagy receptors to depolarized mitochondrial is mediated by NIPSNAP1 and -2. We show 
that NIPSNAP1 and -2 interact with NDP52, p62, NBR1, TAX1BP1, as well as autophagy 
adaptor protein ALFY. ALFY interacts with p62 and is known to facilitate recruitment of the 
autophagy membrane for selective autophagy through its binding to PtdIns3P and GABARAP 
(Clausen et al., 2010; Filimonenko et al., 2010; Lystad et al., 2014). Moreover, we showed 
that the L446A mutant of NDP52, lacking the ability to bind to ubiquitin but does bind to 
NIPSNAP1 and -2, is still recruited to the mitochondria after 6h of CCCP treatment. PARKIN-
dependent ubiquitination of OMM proteins leading to their proteasomal degradation is an early 
event following mitochondrial damage. This event may ‘prime’ the mitochondria for lysosomal 
degradation. This is in line with several studies showing that PARKIN ubiquitination leads to 
proteasomal degradation of OMM proteins (Chan et al., 2011; Geisler et al., 2010; Glauser et 
al., 2011; Shlevkov et al., 2016; Tanaka et al., 2010; Yoshii et al., 2011), and that these events 
occur early and prior to mitophagy (Chan et al., 2011). These early events allow the OMM 
localized NIPSNAP1 and -2 to sustain recruitment of autophagy receptors that is required for 
mitophagy. In addition, we also confirmed the indicated interaction of NIPSNAP1 and -2 with 
ATG8 proteins (Behrends et al., 2010) and show that GABARAPs are the preferred interacting 
partners. Thus, efficient targeting of dysfunctional mitochondria for mitophagy involves 




The function of NIPSNAP1 and -2 in mitophagy is likely specific to PARKIN-
dependent mitophagy. We found NIPSNAP1 to be immunoprecipitated by PARKIN, and  we 
did not see a difference between control and NIPSNAP1 and -2 depleted cells when inducing 
mitophagy by DFP-induced iron depletion, shown to be PARKIN-independent (Allen et al., 
2013). Moreover, depletion of NIPSNAPs did not affect starvation-induced autophagy.  
 
Ablation of Nipsnap1 in zebrafish causes parkinsonism  
PD is characterized by death of dopaminergic neurons in the substantia nigra, linked to 
dysfunctional turnover of mitochondria in these cells (Pickrell and Youle, 2015). Excitingly, 
NIPSNAP1 was identified as the gene being most significantly downregulated in a report 
analyzing genome-wide gene expression data of PD diseased and control samples (Fu and Fu, 
2015). Moreover, NIPSNAP1 was downregulated in a comparative proteomics study of neural 
SH-SY5Y cells responding to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) 
treatment, known to lead to degeneration of dopaminergic neurons (Choi et al., 2014). 
Furthermore, mouse Nipsnap1 is highly expressed in the dopaminergic neurons in midbrain 
and noradrenergic neurons in the brainstem (Nautiyal et al., 2010).  In line with these studies, 
zebrafish depleted of Nipsnap1 displayed reduced mitophagy in the brain. Due to their post-
mitotic state and metabolic requirements, neurons are particularly vulnerable to mitochondrial 
dysfunction. Zebrafish lacking Nipsnap1 showed a significant loss of dopaminergic neurons in 
the diencephalospinal tract of the brain, and the aberrant locomotion phenotype of nipsnap1 
mutants was rescued completely by exogenous addition of 5 mM L-Dopa. Nipsnap1-deficient 
larvae displayed reduced mitophagy and significantly increased ROS production compared to 
WT larvae. Increased ROS activity is suggested as one mechanism for death of dopaminergic 
neurons in PD. Hence, we propose that reduced mitophagy in Nipsnap1-deficient larvae leads 
to increased ROS, which accordingly results in death of dopaminergic neurons.  
Our results are similar to other studies that have modelled PD-related genes in 
zebrafish. parkin, pink1 and lrrk2 knockdown using antisense morpholinos resulted in 
decreased levels of dopaminergic neurons. pink1 morphants had elevated ROS level whereas 
lrrk2 morphants displayed motor defects (Anichtchik et al., 2008; Flinn et al., 2009; Sheng et 
al., 2010). A pink1 TALEN-mediated KO zebrafish line showed 30-40% dopaminergic 
neuronal loss (Zhang et al., 2017). A recent paper showed that autophagy protected 
dopaminergic neurons in a MPTP-induced PD model in zebrafish (Hu et al., 2017). ATG5 
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down-regulation caused a pathological locomotor behavior, loss of dopaminergic neurons and 
accumulation of -Synuclein aggregates, which were reversed by overexpression of ATG5.  
Taken together, our data show that zebrafish lacking a functional Nipsnap1 displays  
parkinsonism, including reduced Th1-positive dopaminergic neurons and dysfunctional 
neuronal motor activity, which was rescued with exogenous addition of L-DOPA. The 
zebrafish Nipsnap1 and -2 proteins show 75% amino acid identity with the corresponding 
human and mouse orthologs. The expression pattern of nipsnap1 and -2 in zebrafish, as in 
mouse and humans, is largely tissue-specific. It is clearly conceivable that our data in zebrafish 
are characteristic for the function of mouse and human NIPSNAPs.  
 
Author contributions 
YPA, SP, BJM, AHL, CB, TMN and MYWN designed and performed the experimental 
research, analysed data, drafted the article and made figures. HBB helped with some 
experiments, TL assisted in analyses of data and experimental design. BT and TMN did the 
MS analysis. AY and CVE provided essential reagents and knowhow, and CVE aided with 
phenotypic analysis for zebrafish experiments. TJ and AS designed the project, analysed the 
data and wrote the final version of the manuscript. 
 
Acknowledgements 
We would like to thank Chara Charsou for help with flow cytometry and the proteomics and 
imaging core facilities at UiT, Faculty of Health Sciences for valuable assistance. This work 
was partly supported by the Research Council of Norway through its Centres of Excellence 
funding scheme (project number 262652) and FRIPRO grants (project number 221831 to AS 
and 249884 to TJ), the Norwegian Cancer Society (AHL, SP, TJ and AS), NINDS R01 
NS063973, NINDS R01 NS077111 and the Parkinson’s disease foundation (AY).  
 
References 
Alemu, E.A., Lamark, T., Torgersen, K.M., Birgisdottir, A.B., Larsen, K.B., Jain, A., Olsvik, H., 
Overvatn, A., Kirkin, V., and Johansen, T. (2012). ATG8 family proteins act as scaffolds for 
assembly of the ULK complex: sequence requirements for LC3-interacting region (LIR) motifs. 
J Biol Chem 287, 39275-39290. 
Allen, G.F., Toth, R., James, J., and Ganley, I.G. (2013). Loss of iron triggers PINK1/Parkin-
independent mitophagy. EMBO Rep 14, 1127-1135. 
Anichtchik, O., Diekmann, H., Fleming, A., Roach, A., Goldsmith, P., and Rubinsztein, D.C. 
(2008). Loss of PINK1 function affects development and results in neurodegeneration in 
zebrafish. J Neurosci 28, 8199-8207. 
18 
 
Behrends, C., Sowa, M.E., Gygi, S.P., and Harper, J.W. (2010). Network organization of the 
human autophagy system. Nature 466, 68-76. 
Birgisdottir, A.B., Lamark, T., and Johansen, T. (2013). The LIR motif - crucial for selective 
autophagy. J Cell Sci 126, 3237-3247. 
Bjorkoy, G., Lamark, T., Brech, A., Outzen, H., Perander, M., Overvatn, A., Stenmark, H., and 
Johansen, T. (2005). p62/SQSTM1 forms protein aggregates degraded by autophagy and has 
a protective effect on huntingtin-induced cell death. J Cell Biol 171, 603-614. 
Chan, N.C., Salazar, A.M., Pham, A.H., Sweredoski, M.J., Kolawa, N.J., Graham, R.L., Hess, 
S., and Chan, D.C. (2011). Broad activation of the ubiquitin-proteasome system by Parkin is 
critical for mitophagy. Hum Mol Genet 20, 1726-1737. 
Chen, W.W., Freinkman, E., Wang, T., Birsoy, K., and Sabatini, D.M. (2016). Absolute 
Quantification of Matrix Metabolites Reveals the Dynamics of Mitochondrial Metabolism. Cell 
166, 1324-1337 e1311. 
Choi, J.W., Song, M.Y., and Park, K.S. (2014). Quantitative proteomic analysis reveals 
mitochondrial protein changes in MPP(+)-induced neuronal cells. Mol Biosyst 10, 1940-1947. 
Clausen, T.H., Lamark, T., Isakson, P., Finley, K., Larsen, K.B., Brech, A., Overvatn, A., 
Stenmark, H., Bjorkoy, G., Simonsen, A., et al. (2010). p62/SQSTM1 and ALFY interact to 
facilitate the formation of p62 bodies/ALIS and their degradation by autophagy. Autophagy 6, 
330-344. 
Dragich, J.M., Kuwajima, T., Hirose-Ikeda, M., Yoon, M.S., Eenjes, E., Bosco, J.R., Fox, L.M., 
Lystad, A.H., Oo, T.F., Yarygina, O., et al. (2016). Autophagy linked FYVE (Alfy/WDFY3) is 
required for establishing neuronal connectivity in the mammalian brain. Elife 5, pii: e14810. 
Duan, L., Hope, J., Ong, Q., Lou, H.Y., Kim, N., McCarthy, C., Acero, V., Lin, M.Z., and Cui, 
B. (2017). Understanding CRY2 interactions for optical control of intracellular signaling. Nature 
communications 8, 547. 
Emran, F., Rihel, J., and Dowling, J.E. (2008). A behavioral assay to measure responsiveness 
of zebrafish to changes in light intensities. J Vis Exp, pii: 923. 
Filimonenko, M., Isakson, P., Finley, K.D., Anderson, M., Jeong, H., Melia, T.J., Bartlett, B.J., 
Myers, K.M., Birkeland, H.C., Lamark, T., et al. (2010). The selective macroautophagic 
degradation of aggregated proteins requires the PI3P-binding protein Alfy. Mol Cell 38, 265-
279. 
Flinn, L., Mortiboys, H., Volkmann, K., Koster, R.W., Ingham, P.W., and Bandmann, O. (2009). 
Complex I deficiency and dopaminergic neuronal cell loss in parkin-deficient zebrafish (Danio 
rerio). Brain 132, 1613-1623. 
Fu, L.M., and Fu, K.A. (2015). Analysis of Parkinson's disease pathophysiology using an 
integrated genomics-bioinformatics approach. Pathophysiology 22, 15-29. 
Geisler, S., Holmstrom, K.M., Skujat, D., Fiesel, F.C., Rothfuss, O.C., Kahle, P.J., and 
Springer, W. (2010). PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and 
p62/SQSTM1. Nat.Cell Biol. 12, 119-131. 
Glauser, L., Sonnay, S., Stafa, K., and Moore, D.J. (2011). Parkin promotes the ubiquitination 
and degradation of the mitochondrial fusion factor mitofusin 1. J Neurochem 118, 636-645. 
Holzschuh, J., Ryu, S., Aberger, F., and Driever, W. (2001). Dopamine transporter expression 
distinguishes dopaminergic neurons from other catecholaminergic neurons in the developing 
zebrafish embryo. Mech Dev 101, 237-243. 
Hoyer-Hansen, M., Bastholm, L., Szyniarowski, P., Campanella, M., Szabadkai, G., Farkas, 
T., Bianchi, K., Fehrenbacher, N., Elling, F., Rizzuto, R., et al. (2007). Control of 
macroautophagy by calcium, calmodulin-dependent kinase kinase-beta, and Bcl-2. Mol Cell 
25, 193-205. 
Hu, Z.Y., Chen, B., Zhang, J.P., and Ma, Y.Y. (2017). Up-regulation of autophagy-related gene 
5 (ATG5) protects dopaminergic neurons in a zebrafish model of Parkinson's disease. J Biol 
Chem 292, 18062-18074. 
Isakson, P., Lystad, A.H., Breen, K., Koster, G., Stenmark, H., and Simonsen, A. (2013). 
TRAF6 mediates ubiquitination of KIF23/MKLP1 and is required for midbody ring degradation 
by selective autophagy. Autophagy 9, 1955-1964. 
19 
 
Jain, A., Lamark, T., Sjottem, E., Bowitz, L.K., Awuh, J.A., Overvatn, A., McMahon, M., Hayes, 
J.D., and Johansen, T. (2010). p62/SQSTM1 is a target gene for transcription factor NRF2 
and creates a positive feedback loop by inducing antioxidant response element-driven gene 
transcription. Journal of Biological Chemistry 285(29):22576-91. 
Jao, L.E., Wente, S.R., and Chen, W. (2013). Efficient multiplex biallelic zebrafish genome 
editing using a CRISPR nuclease system. Proc Natl Acad Sci U S A 110, 13904-13909. 
Kane, L.A., Lazarou, M., Fogel, A.I., Li, Y., Yamano, K., Sarraf, S.A., Banerjee, S., and Youle, 
R.J. (2014). PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity. J 
Cell Biol 205, 143-153. 
Kazlauskaite, A., Kondapalli, C., Gourlay, R., Campbell, D.G., Ritorto, M.S., Hofmann, K., 
Alessi, D.R., Knebel, A., Trost, M., and Muqit, M.M. (2014). Parkin is activated by PINK1-
dependent phosphorylation of ubiquitin at Ser65. Biochem J 460, 127-139. 
Kettleborough, R.N., Busch-Nentwich, E.M., Harvey, S.A., Dooley, C.M., de Bruijn, E., van 
Eeden, F., Sealy, I., White, R.J., Herd, C., Nijman, I.J., et al. (2013). A systematic genome-
wide analysis of zebrafish protein-coding gene function. Nature 496, 494-497. 
Kim, M.J., Kang, K.H., Kim, C.H., and Choi, S.Y. (2008). Real-time imaging of mitochondria in 
transgenic zebrafish expressing mitochondrially targeted GFP. Biotechniques 45, 331-334. 
Komatsu, M., Waguri, S., Koike, M., Sou, Y.S., Ueno, T., Hara, T., Mizushima, N., Iwata, J., 
Ezaki, J., Murata, S., et al. (2007). Homeostatic levels of p62 control cytoplasmic inclusion 
body formation in autophagy-deficient mice. Cell 131, 1149-1163. 
Kondapalli, C., Kazlauskaite, A., Zhang, N., Woodroof, H.I., Campbell, D.G., Gourlay, R., 
Burchell, L., Walden, H., Macartney, T.J., Deak, M., et al. (2012). PINK1 is activated by 
mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by 
phosphorylating Serine 65. Open Biol 2, 120080. 
Koyano, F., Okatsu, K., Kosako, H., Tamura, Y., Go, E., Kimura, M., Kimura, Y., Tsuchiya, H., 
Yoshihara, H., Hirokawa, T., et al. (2014). Ubiquitin is phosphorylated by PINK1 to activate 
parkin. Nature 510, 162-166. 
Kulawiak, B., Hopker, J., Gebert, M., Guiard, B., Wiedemann, N., and Gebert, N. (2013). The 
mitochondrial protein import machinery has multiple connections to the respiratory chain. 
Biochim Biophys Acta 1827, 612-626. 
Lamark, T., Perander, M., Outzen, H., Kristiansen, K., Overvatn, A., Michaelsen, E., Bjorkoy, 
G., and Johansen, T. (2003). Interaction codes within the family of mammalian Phox and 
Bem1p domain-containing proteins. Journal of Biological Chemistry 278, 34568-34581. 
Lamb, C.A., Yoshimori, T., and Tooze, S.A. (2013). The autophagosome: origins unknown, 
biogenesis complex. Nat Rev Mol Cell Biol 14, 759-774. 
Lambert, A.M., Bonkowsky, J.L., and Masino, M.A. (2012). The conserved dopaminergic 
diencephalospinal tract mediates vertebrate locomotor development in zebrafish larvae. J 
Neurosci 32, 13488-13500. 
Lazarou, M., Sliter, D.A., Kane, L.A., Sarraf, S.A., Wang, C., Burman, J.L., Sideris, D.P., Fogel, 
A.I., and Youle, R.J. (2015). The ubiquitin kinase PINK1 recruits autophagy receptors to 
induce mitophagy. Nature 524, 309-314. 
Lystad, A.H., Ichimura, Y., Takagi, K., Yang, Y., Pankiv, S., Kanegae, Y., Kageyama, S., 
Suzuki, M., Saito, I., Mizushima, T., et al. (2014). Structural determinants in GABARAP 
required for the selective binding and recruitment of ALFY to LC3B-positive structures. EMBO 
Rep 15, 557-565. 
Mandell, M.A., Jain, A., Arko-Mensah, J., Chauhan, S., Kimura, T., Dinkins, C., Silvestri, G., 
Munch, J., Kirchhoff, F., Simonsen, A., et al. (2014). TRIM Proteins Regulate Autophagy and 
Can Target Autophagic Substrates by Direct Recognition. Dev Cell 30, 394-409. 
Meeker, N.D., Hutchinson, S.A., Ho, L., and Trede, N.S. (2007). Method for isolation of PCR-
ready genomic DNA from zebrafish tissues. Biotechniques 43, 610, 612, 614. 
Mugoni, V., Camporeale, A., and Santoro, M.M. (2014). Analysis of oxidative stress in 
zebrafish embryos. J Vis Exp Jul 7;(89). doi: 10.3791/51328. 
Nautiyal, M., Sweatt, A.J., MacKenzie, J.A., Mark Payne, R., Szucs, S., Matalon, R., Wallin, 
R., and Hutson, S.M. (2010). Neuronal localization of the mitochondrial protein NIPSNAP1 in 
rat nervous system. Eur J Neurosci 32, 560-569. 
20 
 
Nyfeler, B., Reiterer, V., Wendeler, M.W., Stefan, E., Zhang, B., Michnick, S.W., and Hauri, 
H.P. (2008). Identification of ERGIC-53 as an intracellular transport receptor of alpha1-
antitrypsin. J Cell Biol 180, 705-712. 
Okatsu, K., Saisho, K., Shimanuki, M., Nakada, K., Shitara, H., Sou, Y.S., Kimura, M., Sato, 
S., Hattori, N., Komatsu, M., et al. (2010). p62/SQSTM1 cooperates with Parkin for perinuclear 
clustering of depolarized mitochondria. Genes Cells 15, 887-900. 
Pankiv, S., Clausen, T.H., Lamark, T., Brech, A., Bruun, J.A., Outzen, H., Overvatn, A., 
Bjorkoy, G., and Johansen, T. (2007). p62/SQSTM1 Binds Directly to Atg8/LC3 to Facilitate 
Degradation of Ubiquitinated Protein Aggregates by Autophagy. Journal of Biological 
Chemistry 282, 24131-24145. 
Pickrell, A.M., and Youle, R.J. (2015). The roles of PINK1, parkin, and mitochondrial fidelity in 
Parkinson's disease. Neuron 85, 257-273. 
Pohl, C., and Jentsch, S. (2009). Midbody ring disposal by autophagy is a post-abscission 
event of cytokinesis. Nat.Cell Biol. 11, 65-70. 
Ran, F.A., Hsu, P.D., Wright, J., Agarwala, V., Scott, D.A., and Zhang, F. (2013). Genome 
engineering using the CRISPR-Cas9 system. Nat Protoc 8, 2281-2308. 
Rigbolt, K.T., Zarei, M., Sprenger, A., Becker, A.C., Diedrich, B., Huang, X., Eiselein, S., 
Kristensen, A.R., Gretzmeier, C., Andersen, J.S., et al. (2014). Characterization of early 
autophagy signaling by quantitative phosphoproteomics. Autophagy 10, 356-371. 
Rogov, V., Dotsch, V., Johansen, T., and Kirkin, V. (2014). Interactions between autophagy 
receptors and ubiquitin-like proteins form the molecular basis for selective autophagy. Mol Cell 
53, 167-178. 
Sarraf, S.A., Raman, M., Guarani-Pereira, V., Sowa, M.E., Huttlin, E.L., Gygi, S.P., and 
Harper, J.W. (2013). Landscape of the PARKIN-dependent ubiquitylome in response to 
mitochondrial depolarization. Nature 496, 372-376. 
Sheng, D., Qu, D., Kwok, K.H., Ng, S.S., Lim, A.Y., Aw, S.S., Lee, C.W., Sung, W.K., Tan, 
E.K., Lufkin, T., et al. (2010). Deletion of the WD40 domain of LRRK2 in Zebrafish causes 
Parkinsonism-like loss of neurons and locomotive defect. PLoS Genet 6, e1000914. 
Shlevkov, E., Kramer, T., Schapansky, J., LaVoie, M.J., and Schwarz, T.L. (2016). Miro 
phosphorylation sites regulate Parkin recruitment and mitochondrial motility. Proc Natl Acad 
Sci U S A 113, E6097-E6106. 
Simonsen, A., Birkeland, H.C., Gillooly, D.J., Mizushima, N., Kuma, A., Yoshimori, T., 
Slagsvold, T., Brech, A., and Stenmark, H. (2004). Alfy, a novel FYVE-domain-containing 
protein associated with protein granules and autophagic membranes. J Cell Sci. 117, 4239-
4251. 
Stolz, A., Ernst, A., and Dikic, I. (2014). Cargo recognition and trafficking in selective 
autophagy. Nat Cell Biol 16, 495-501. 
Tanaka, A., Cleland, M.M., Xu, S., Narendra, D.P., Suen, D.F., Karbowski, M., and Youle, R.J. 
(2010). Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by 
Parkin. J Cell Biol 191, 1367-1380. 
Thisse, C., and Thisse, B. (2008). High-resolution in situ hybridization to whole-mount 
zebrafish embryos. Nat Protoc 3, 59-69. 
Thurston, T.L., Wandel, M.P., von Muhlinen, N., Foeglein, A., and Randow, F. (2012). Galectin 
8 targets damaged vesicles for autophagy to defend cells against bacterial invasion. Nature 
482, 414-418. 
Truscott, K.N., Brandner, K., and Pfanner, N. (2003). Mechanisms of protein import into 
mitochondria. Curr Biol 13, R326-337. 
Tumbarello, D.A., Waxse, B.J., Arden, S.D., Bright, N.A., Kendrick-Jones, J., and Buss, F. 
(2012). Autophagy receptors link myosin VI to autophagosomes to mediate Tom1-dependent 
autophagosome maturation and fusion with the lysosome. Nat Cell Biol 14, 1024-1035. 
Wei, Y., Chiang, W.C., Sumpter, R., Jr., Mishra, P., and Levine, B. (2017). Prohibitin 2 Is an 
Inner Mitochondrial Membrane Mitophagy Receptor. Cell 168, 224-238 e210. 
Xie, X., Li, F., Wang, Y., Wang, Y., Lin, Z., Cheng, X., Liu, J., Chen, C., and Pan, L. (2015). 




Yoshii, S.R., Kishi, C., Ishihara, N., and Mizushima, N. (2011). Parkin mediates proteasome-
dependent protein degradation and rupture of the outer mitochondrial membrane. J Biol Chem 
286, 19630-19640. 
Zhang, Y., Nguyen, D.T., Olzomer, E.M., Poon, G.P., Cole, N.J., Puvanendran, A., Phillips, 
B.R., and Hesselson, D. (2017). Rescue of Pink1 Deficiency by Stress-Dependent Activation 
of Autophagy. Cell Chem Biol 24, 471-480 e474. 
Zheng, Y.T., Shahnazari, S., Brech, A., Lamark, T., Johansen, T., and Brumell, J.H. (2009). 
The adaptor protein p62/SQSTM1 targets invading bacteria to the autophagy pathway. Journal 
of Immunology 183, 5909-5916. 
Zhong, Z., Umemura, A., Sanchez-Lopez, E., Liang, S., Shalapour, S., Wong, J., He, F., 
Boassa, D., Perkins, G., Ali, S.R., et al. (2016). NF-kappaB Restricts Inflammasome Activation 
via Elimination of Damaged Mitochondria. Cell 164, 896-910. 
 
Figure titles and legends 
Figure 1. NIPSNAP1 and NIPSNAP2 are novel binding partners of autophagy-related 
proteins.  
A-B. Schematic representation of co-immunoprecipitation experiments. Endogenous ALFY 
was immunoprecipitated from wild-type (WT) or ALFY-/- MEF lysates (A) and stably-
transfected EGFP or EGFP-tagged p62 were immunoprecipitated from HEK293 cells (B), 
followed by mass spectrometry identification of interacting proteins. Only the proteins showing 
a specific interaction with ALFY or p62 are shown.  
C. Immunoblotting for NIPSNAP1 and NIPSNAP2 in different mouse tissues. Each tissue is 
represented by two independent mice. BAT: brown adipose tissue, eWAT and sWAT: 
epididymal and visceral white adipose tissue.  
D. ALFY and p62 both co-immunoprecipitate with NIPSNAP1 independent of each other. 
EGFP or NIPSNAP1-EGFP were pulled down from U2OS cells transiently transfected with 
the indicated siRNA and plasmids. Protein levels in cell lysates (input) and immunoprecipitates 
were visualized by immunoblotting using the indicated antibodies.  
E. NIPSNAP1 and NIPSNAP2 interact with selective autophagy receptors. The indicated 
MYC-tagged autophagy receptors were in vitro translated in the presence of [35S]-methionine 
and their binding to GST-tagged NIPSNAP1 and NIPSNAP2 immobilized on glutathione-
sepharose beads analyzed. Bound MYC-tagged proteins were detected by autoradiography 
(AR) and the GST proteins by Coomassie Brilliant Blue (CBB).  
F. NIPSNAP1 and NIPSNAP2 interact with all human ATG8 proteins. GST-tagged hATG8 
proteins immobilized on glutathione-sepharose beads were incubated with in vitro translated 
full-length MYC-NIPSNAP1 and NIPSNAP2. Bound MYC-tagged proteins were detected by 
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autoradiography (AR) and GST-tagged proteins by coomassie brilliant blue (CBB) staining. 
Densitometric analysis was done using Science Lab. Image gauge (Fujifilm) from three 
independent experiments.  Values are mean ± s.d. ***p ˂ 0.001, **p ˂ 0.005 *p ˂ 0.01; one-
way ANOVA. 
 
Figure 2. NIPSNAP1 and NIPSNAP2 contain two mitochondrial targeting signals for 
localization to the matrix and the surface. 
A. NIPSNAP1 and NIPSNAP2 co-purifies with PDH and TOMM20 in the mitochondrial 
fraction. Subcellular fractions isolated using the QProteome mitochondria isolation kit 
(Quiagen) from HeLa cells were subjected to SDS-PAGE and immunoblotting with the 
indicated antibodies. 
B. NIPSNAP1 is primarily an intra-mitochondrial protein. Mitochondria were isolated by 
differential centrifugation from HeLa cells and subjected to 50 g/ml proteinase K (PK) 
digestion in the presence or absence of 1% Triton X-100 and osmotic shock followed by 
immunoblotting with the indicated antibodies. 
C. Mitochondrial fractions from HeLa cells were incubated in mitochondrial-buffer alone or 
mitochondrial-buffer containing Na2CO3 (pH 11.5) and centrifuged at 16.000 x g for 15 min. 
The pellets (P) and supernatant (S) fractions were immunoblotted with indicated antibodies. 
CYT-C, cytochrome C. 
D. The N-terminal of NIPSNAP1/2 is necessary and sufficient for mitochondrial localization. 
HeLa cells were transfected with either full length, EGFP tagged NIPSNAP1/2 or the indicated 
deletion constructs. The NIPSNAP1/2 regions expressed are indicated in green (schematic 
figures below the images). 
E. The N-terminal 23 amino acids of NIPSNAP1 facilitate its mitochondrial import. In vitro 
translated 35S-labeled full-length or deletion mutant (amino acids 24-284) of NIPSNAP1 were 
incubated with isolated mitochondria in mitochondrial import assay buffer for 45 min at 37˚C, 
then washed three times, treated with PK and subjected to SDS-PAGE and autoradiography.  
F. NIPSNAP1 amino acids 24-64 functions as a mitochondrial affinity signal. HeLa cells were 
transiently transfected with NIPSNAP1-EGFP deletion mutants (amino acids 24-284 or 24-64) 
for 24 h before confocal imaging.  
G. Full length and NIPSNAP1 (24-284) localize to different mitochondrial compartments. 
HeLa cells were transfected with the indicated constructs and imaged 24 h after.  
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All scale bars are 10 m. Region of insets are indicated. All results are representative of at least 
three independent experiments.  
 
Figure 3. NIPSNAP1 is enriched on the outer mitochondrial membrane upon 
depolarization. 
A.  NIPSNAP1-3XFLAG is present both inside (left image) and outside (right image) of 
mitochondria. Representative images of the two phenotypes of subcellular distribution of 
transiently transfected NIPSNAP1-3xFLAG in U2OS cells and the frequency of both 
phenotypes, quantified in untreated and CCCP-treated cells. Values are mean ± s.d. *p < 0.05 
(unpaired Student’s t test). 
B. NIPSNAP1-EGFP-CIB1 can localize to the surface of mitochondria. HeLa cells were 
transiently transfected with NIPSNAP1-EGFP-CIB1 and CRY2low-tdTomato. 24h after 
transfection CRY2 was activated by 5 sec pulse of blue light (475nm, 20mW/cm2) and imaged 
on Zeiss AxioObserver Z1 fluorescent microscope. A schematic outline is shown in the right 
panel.  
C. HeLa cells stably transfected with SUMOstar-NIPSNAP1-EGFP under control of a 
constitutive CMV promoter and SUMOstar protease under control of tet-on regulated CMV 
promoter were treated for 5 h with 1 µg/ml tetracycline followed by 5 h treatment with 10 µM 
CCCP and 1g/ml tetracycline, followed by 15 min incubation with 50 nM Mitotracker Red. 
All scale bars are 10 m. A schematic outline is shown in the right panel.  
D. NIPSNAP1 can be used as an affinity tag for purification of mitochondria. HeLa cells stably 
transfected with NIPSNAP1-EGFP-3xHA, NIPSNAP1-EGFP-3xFLAG or another 
mitochondrial matrix protein, PDH-EGFP-3xHA, were treated with 20 μM of CCCP for 
indicated periods of time or left untreated (NT), then lysed in KPBS under non-detergent 
conditions and subjected to immunoprecipitation with magnetic beads, conjugated to anti-HA 
antibody for 5 min. Immunoprecipitates and input lysates were immunoblotted with the 
indicated antibodies. 
E. The mitochondrial fraction from HeLa mCherry-Parkin cells treated or not with OA or 
CCCP for 3 h, was incubated in mitochondrial-buffer alone or mitochondrial-buffer containing 
Na2CO3 (pH 11.5) and centrifuged at 16.000 x g for 15 min.. The pellets (P) and supernatant 
(S) fractions were immunoblotted with the indicated antibodies.  
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F. Mitochondria isolated from HeLa mCherry-Parkin cells treated with O/A for 3h were 
subjected to sodium carbonate (Na2CO3, pH 11.5) extraction in the presence or absence of 15 
µg/ml proteinase K. The indicated mitochondrial proteins were analyzed by immunoblotting. 
G. NIPSNAP1 mitochondrial import, but not mitochondrial binding, is dependent on an intact 
mitochondrial membrane potential. In vitro translated 35S-labeled NIPSNAP1 was incubated 
with untreated or FCCP-treated mitochondria from HeLa or U2OS cells in mitochondrial 
import buffer for 45 min at 37˚C, washed three times, treated with PK and subjected to SDS 
PAGE and autoradiography. 
All scale bars are 10 m. Region of insets are indicated. All results are representative of three 
independent experiments. 
 
Figure 4. Increased interaction of NIPSNAP1 with autophagy proteins upon 
mitochondria membrane depolarization. 
A. HeLa PARKIN cells transiently transfected with 3xFLAG or 3xFLAG-p62 were treated 
with 10 µM CCCP or exposed to hypoxia (1% O2) for 6 h. Cells were lysed and 
immunoprecipitated with FLAG resin. Protein levels in cell lysates (input) and 
immunoprecipitates were detected by immunoblotting using the indicated antibodies. 
B. Densitometric analysis of results shown in (A) from 3 independent experiments.  ***p ˂ 
0.001; one-way ANOVA. 
C. HeLa cells stably expressing either EGFP or NIPSNAP-EGFP were treated as in (A) 
followed by GFP-trap immunoprecipitation. Co-immunoprecipitation of p62 and NDP52 was 
detected by immunoblotting. 
D-E. Quantification of immunoprecipitation results shown in (C) based on 3 independent 
experiments.  ***p ˂ 0.001, **p ˂ 0.01; one-way ANOVA. 
F. U2OS cells were transiently transfected with NIPSNAP1 and GABARAP fused to split-
YFP1 or split-YFP2, respectively, then treated 24 h after transfection with 10 µM CCCP for 4 
h, stained with 50 nM of Mitotracker Red for 20 min and subjected to confocal microscopy. 
Scale bars are 10 m. 
G. U2OS cells were transiently transfected with NIPSNAP1-3xFLAG, treated or not with 10 
µM CCCP overnight, stained with anti-FLAG together with anti-LC3B or anti-ALFY 
antibodies and subjected to confocal imaging. Scale bars are 10 m. 
 
Figure 5. NIPSNAP1 and NIPSNAP2 are required for mitophagy.  
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A. CRISPR/Cas9-mediated knockout of NIPSNAP1 and NIPSNAP2 (N1/N2 DKO) and ATG7 
in HeLa cells were confirmed by immunoblotting. The effect of ATG7 KO on autophagy was 
confirmed by immunoblotting against LC3B and GABARAP.   
B. WT, NIPSNAP1 and NIPSNAP2 double knockout (N1/N2 DKO) and ATG7 knockout 
HeLa cells with or without mCherry-PARKIN expression were treated with OA for 12 or 24 h 
and extracts immunoblotted with the indicated antibodies. 
C. Densitometric analysis of COXII protein levels relative to WT in (B). Values are mean ± 
s.d. from three independent experiments. ***p ˂ 0.001, one-way ANOVA. 
D. Representative images of mCherry-Parkin expressing WT, N1/N2 DKO and ATG7 KO cells 
treated with OA for 6 or 24 h, immunostained for mtDNA nucleoids (green) and DAPI (blue).  
Scale bars are 20 m. 
E. Quantification of mtDNA nucleoid staining of data shown in (D). More than 100 cells were 
quantified per sample. Similar results were obtained in three independent experiments. Values 
are mean ± s.d. ***p ˂ 0.001, one-way ANOVA. 
F. WT, N1/N2 DKO and ATG7 KO HeLa cells stably expressing the mCherry-EGFP-
OMP25TM mitophagy reporter were either left untreated or treated with OA for 6h and 
analyzed by confocal microscopy. Scale bars are 10 m. 
G. mCherry-Parkin expressing WT, and N1/N2 DKO HeLa cells were rescued or not with 
untagged NIPSNAP1 or NIPSNAP2, followed by treatment with OA for 12 or 24 h and 
immunoblotted with the indicated antibodies. 
H. Quantification of COXII levels relative to WT from data shown in (F). Values are mean ± 
s.d. from three different experiments. ***p ˂ 0.001, **p ˂ 0.005, one-way ANOVA. 
I. Representative images of mCherry-Parkin expressing N1/N2 DKO cells rescued or not with 
NIPSNAP1 or NIPSNAP2 treated with OA for 6 or 24 h, then immunostained for mtDNA 
nucleoids (green) and DAPI (blue). Scale bars are 20 m. 
J. Quantification of mtDNA staining of data shown in (I). More than 100 cells were quantified 
for each treatment. Similar results were obtained in three independent experiments. Values are 
mean ± s.d.  **p ˂ 0.005, one-way ANOVA. 
 
Figure 6. NIPSNAP1 and NIPSNAP2 are required for recruitment of autophagy 
receptors to depolarized mitochondria. 
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A. WT, N1/N2 DKO cells and N1/N2 DKO cells rescued with untagged NIPSNAP2 or 
NIPSNAP2 1-24 and stably expressing mCherry-PARKIN were treated with OA for 12 or 24 
h and immunoblotted with the indicated antibodies.  
B. Densitometric analysis of COXII protein levels relative to WT from data shown in (A). 
Values are mean ± s.d. from three independent experiments. ***p ˂ 0.001, **p ˂ 0.005, one-
way ANOVA. 
C. Whole cell lysate and mitochondria fraction from WT and N1/N2 DKO cells stably 
expressing mCherry-PARKIN were treated with CCCP with or without MG132 and subjected 
to immunoblotting with indicated antibodies. Ponceau S staining of proteins was used as 
loading control. 
D. Domain structure of NDP52 indicating binding sites for Myosin VI, Galectin 8 and 
ubiquitin. The amino acids indicated in red are point mutations (mutated to alanines) that affect 
ubiquitin binding to the zinc finger (ZF2) domain. The LIR required for interaction with 
hATG8 proteins is annotated in green. 
E. MYC-tagged NDP52 WT and indicated mutants were in vitro translated in the presence of 
[35S]-methionine and used in GST-pulldown assay with GST-tagged NIPSNAP1, NIPSNAP2, 
ubiquitin, 4x-ubiquitin and Galectin 8. Bound Myc-tagged proteins were detected by 
autoradiography (AR) and the GST proteins by Coomassie Brilliant Blue (CBB). 
F. NDP52 KO HeLa cells were either transiently co-transfected with mCherry-Parkin and 
EGFP or EGFP-tagged NDP52 WT and mutants (indicated in D) and thereafter treated with 
CCCP for 6h. Recruitment of EGFP tagged proteins to mitochondria were analyzed by confocal 
microscopy. Mitochondria were stained with an antibody against TIMM23. Regions of insert 
are indicated. Scale bars are 10 m. 
 
Figure 7. Nipsnap1 deficient zebrafish larvae display parkinsonism. 
A. Spatial expression pattern of nipsnap1 across the different development stages of zebrafish 
as demonstrated by whole-mount in situ hybridization at the indicated stages. All embryos are 
in lateral view. Scale bar - 200 µm. 
B. Representative images of WT, nipsnap1 mutant and rescue (nipsnap1 mutant + zebrafish 
nipsnap1 mRNA) transgenic tandem-tagged mitofish larvae at 3 dpf. Images were taken from 
the head region of the respective zebrafish larvae. Scale bars are 20 µm. 
C. Quantification of the ratio of red puncta to yellow puncta (representative of mitophagy) per 
cell. An average of 15 cells from each of 25 larvae for WT, nipsnap1 mutant and nipsnap1 
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mutant + rescue, tandem-tagged mitofish larvae from three independent experiments were used 
for quantification.   
D. WT, nipsnap1-/- and nipsnap1 mutant embryos at 3 dpf were dissociated into single cells 
prior to incubation with 10 μM CellROX for 30 min at 28 °C in the dark. ROS levels were 
quantified by FACS analysis from six independent experiments.  
E. Spatial expression pattern of tyrosine hydroxylase 1 (th1) gene in WT, nipsnap1-/- and 
nipsnap1 mutant embryos at 3 dpf as determined by whole-mount in situ hybridization. 
Orientation dorsal. Scale bar is 200 µm.  
F. Quantification of the number of Th1 positive neurons from images in (D). 10 WT, 20 mutant 
and 20 knockout larvae were used for quantification. Values were normalized to WT control.  
G. Representative immunoblotting images of Nipsnap1, Th1 and β-tubulin on whole embryo 
lysates of WT, Nipsnap1-/- and Nipsnap1 mutant embryos at 3 dpf with β-tubulin as loading 
control.   
H. Representative images of TUNEL assay performed on WT, Nipsnap1 mutant and DNase-
treated WT larvae (positive control) at 3dpf. Orientation lateral. Scale bar is 200 µm. 
I. Quantification of the mean fluorescent intensity measured from the demarcated region (as 
shown in figure H) from images in (H). 10 control (WT), 15 Nipsnap1 mutant and 10 positive 
control larvae were used for quantification respectively. Values were normalized to WT 
control. 
J. Motility analysis of WT and nipsnap1 mutant embryos at 7 dpf using the ‘Zebrabox’ 
automated videotracker (Viewpoint, Lyon). The assay was carried out during daytime, over 
one cycle of 20 min exposure to light (white horizontal bar) followed by 20 min of darkness 
(black horizontal bar). Vertical bars indicate average distance moved during 5 min intervals. 
Controls and nipsnap1 mutants were treated or not with 5 mM of L-Dopa for 1 h, after which 
they were analyzed for motility. Each group consisted of 20-24 larvae.  
All error bars indicate Standard Error of Mean (S.E.M). *p < 0.05, **p < 0.005, ***p < 0.0005, 




Cell culture   
Human cells (U2OS, HeLa and HEK293) were all from ATCC and were maintained in DMEM 
supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin.  The derivation 
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and culturing conditions for the Alfy+/+, Alfy-/- and p62-/- mouse embryonic fibroblasts (MEFs) 
have been described elsewhere (Dragich et al., 2016; Komatsu et al., 2007).   
 
Mouse and zebrafish husbandry  
Male C57BL/6J wild-type (WT) mice were housed in a temperature-controlled (22°C) facility 
with a strict 12 h light/dark cycle and free access to water and food at all times. The mice were 
euthanized by cervical dislocation and tissues were snap-frozen in liquid nitrogen and stored at 
-80°C. Proteins were extracted from mouse tissues with a precipitation buffer (50 mM Tris/HCl 
pH 7.4, 150 mM sodium chloride, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 2 mM 
EDTA). Equal amount of protein was resolved by SDS/PAGE and immunoblotted with 
indicated antibodies. Fish (WT strains and the nipsnap1 mutant lines) were held at the zebrafish 
facility at the Centre for Molecular Medicine Norway (AVD.172) using standard practices. 
Embryos were incubated in egg water (0.06 g/L salt (Red Sea)) or E3 medium (5 mM NaCl, 
0.17 mM KCl, 0.33 mM CaCl2, 0.33 mM MgSO4, equilibrated to pH 7.0). From 12 hpf, 
0.003% (w/v) 1-phenyl-2-thiourea (Sigma-Aldrich) was used to inhibit pigmentation. 
Embryos were held at 28 °C in an incubator following collection. All use of animals was 
approved and registered by the Norwegian Animal Research authority. Experimental 
procedures followed the recommendations of the Norwegian Regulation on Animal 
Experimentation (“Forskrift om forsøk med dyr” fra 15.jan.1996). All experiments conducted 
on larvae at 7 dpf were approved by Mattilsynet (FDF Saksnr. 16/153907). 
 
Chemicals 
The following kits and chemicals were used: KAPA SYBR® FAST qPCR Kits (KAPA 
Biosystems  #KK4601), DIG RNA Labelling Mix (Roche #11277073910), Anti-Digoxigenin 
AP fragments (Roche #11093274910), Proteinase K (PK) (Roche #3115828001), QProteome 
mitochondria isolation kit (Qiagen, #37612), TnT T7 coupled reticulocyte lysate system 
(Promega, #L4610), CellRox (Thermo Fisher Scientific #C10422), Propidium Iodide (Thermo 
Fisher Scientific # P1304MP), FCCP, L-Dopa (#333786), Formamide (#S4117), Torula Yeast 
RNA (#R6625), Heparin Sodium Salt (#H4784), Collagenase P (Sigma, #11249002001), 
SP6/T7 mMessage mMachine (Ambion #AM1340M/#AM1344), 10 µM Oligomycin (Sigma, 
#495455 or  #04876) and 4 µM Antimycin A (Sigma, #A8674), 10 µM Carbonyl cyanide m-
chlorophenyl hydrazine CCCP (Sigma, #C2759), Hanks Balanced Salt Solution (HBSS) 
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(Sigma, #H8264), Bafilomycin A1 (Sigma, #B1793), MG132 (Z-Leu-Leu-Leu-al) (Sigma, 
#C2211) and Ponceau S (Sigma, #P3504). 
  
Antibodies and siRNA 
The following antibodies were used for human cells: rabbit monoclonal anti-NIPSNAP1 
antibody (Cell Signaling, #D1Y6S), rabbit polyclonal anti-NIPSNAP1 antibody (Abcam, 
#ab67302 and #ab133840), mouse monoclonal anti-NIPSNAP2 antibody (LSBio, #LS-
B13280), rabbit polyclonal anti-NIPSNAP2 antibody (ABGENT, # AP6752c), rabbit 
polyclonal anti-NIPSNAP2 antibody (Abcam, #ab153833), rabbit polyclonal anti-ALFY 
antibody (Simonsen et al., 2004), rabbit polyclonal anti-GFP antibody (Abcam, #ab290) and 
(Santa-Cruz; #sc-8334), mouse monoclonal anti-GFP antibody (Clontech, 632381), mouse 
monoclonal anti-MYC tag antibody (Cell Signaling, #2276), mouse monoclonal anti-HA tag 
antibody (Roche, #11583816001), anti-p62 mouse monoclonal (BD Biosciences, #610833) and 
guinea pig polyclonal (Progen, #GP62-C) antibodies, rabbit polyclonal anti-CALCOCO2 
Antibody (Sigma, # HPA023195), mouse monoclonal anti-NBR1 antibody (Santa Cruz, #sc-
130380), rabbit polyclonal Anti-TAX1BP1 antibody (Sigma, #HPA024432), rabbit polyclonal 
Anti-OPTINEURIN antibody (Sigma, #HPA003360), mouse monoclonal anti-MTCO2 
antibody (Abcam, # ab110258), Mouse monoclonal anti-DNA antibody (Progen, #61014), 
rabbit polyclonal anti-SOD-2 antibody (Santa Cruz, # sc-30080), mouse monoclonal anti-
MFN2 antibody (Santa Cruz, #sc-100560), mouse monoclonal anti-UBIQUITIN (FK2) 
antibody (Enzo, #BML-PW8810), rabbit monoclonal anti-ATG7 antibody (Cell Signaling, 
#D12B11), rabbit polyclonal anti-Actin antibody (Sigma, #A2066), rabbit polyclonal anti-PDH 
antibody (Cell Signaling, #2784S), mouse monoclonal anti-Cytochrome-C antibody (Abcam, 
# ab110325), rabbit polyclonal anti-Parkin antibody (Cell Signaling, #2132), rabbit polyclonal 
anti-LC3B antibody (Novusbio, # NB100-2220), mouse monoclonal anti-GABARAP antibody 
(MBL, # M135-3), rabbit polyclonal anti-LC3B antibody (Sigma, # L7543), mouse monoclonal 
anti-TOMM20 antibody (Santa Cruz, 17764), rabbit polyclonal anti-TOMM20 antibody (Santa 
Cruz, # sc-11415), mouse monoclonal anti-TOMM40 antibody (Santa Cruz, # sc-365467), 
rabbit polyclonal anti-IKKα antibody (Cell Signaling, 2682), rabbit polyclonal anti-histone H3 
antibody (Abcam, ab1791), mouse monoclonal anti-TIMM23 antibody (BD Biosciences, 
#611223), mouse monoclonal anti-FLAG epitope M2 antibody (Sigma, F1804), rabbit 
monoclonal anti-DYKDDDDK-tag (FLAG-tag) antibody (Cell Signaling, 14793S). The 
following antibodies were used for zebrafish: rabbit polyclonal anti-Nipsnap1 (Abcam, 
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ab133840) and Nipsnap2 (Abcam, ab153833), mouse monoclonal anti-tyrosine hydroxylase 
(TH) (Immunostar, 22941) and mouse monoclonal anti-α-Tubulin (Sigma, T5168).  
All siRNAs were purchased from Dharmacon Inc. The target sequences include NIPSNAP1 
(CCAGGAACCAUGAUCGAGU, CGUAACAGGAACUCGGAAG), NIPSNAP2 
(GCCAAAGAUUCACGAAGAU) and ATG7 (CAGUGGAUCUAAAUCUCAAACUGAU) 
(Hoyer-Hansen et al., 2007). 
 
Plasmids   
Plasmids used in this work: 
Vector Description Source 
pEGFP-N3 Mammalian expression vector for C-terminal 
fusion of EGFP 
Clontech 
pGEX-5X3 Bacterial GST expression vector GE Healthcare 
pEGFP-N3-NIPSNAP1 Human NIPSNAP1 with C-terminal EGFP fusion This study 
pEGFP-N3-NIPSNAP1(1-20) Deletion mutant of NIPSNAP1 aa. 1-20 with C-
terminal EGFP fusion 
This study 
pEGFP-N3-NIPSNAP1(24-284) Deletion mutant of NIPSNAP1 aa. 24-284 with 
C-terminal EGFP fusion 
This study 
pEGFP-N3-NIPSNAP1(59-284) Deletion mutant of NIPSNAP1 aa. 59-284 with 
C-terminal EGFP fusion 
This study 
pEGFP-N3-NIPSNAP1(24-64) Deletion mutant of NIPSNAP1 aa. 24-64 with C-
terminal EGFP fusion 
This study 
pmCherry-N3-NIPSNAP1 Human NIPSNAP1 with C-terminal mCherry 
fusion 
This study 
p-3xFLAG-N3-NIPSNAP1 Human NIPSNAP1 with C-terminal 3xFLAG 
fusion 
This study 
pTH1-NIPSNAP1 Human NIPSNAP1 with N-terminal MBP fusion This study 
pNIPSNAP1 Untagged human NIPSNAP1 This study 
 
pDestEGFP-LC3A Human LC3A with N-terminal EGFP fusion (Alemu et al., 2012) 
pDestEGFP-LC3B Human LC3B with N-terminal EGFP fusion (Alemu et al., 2012) 
pDestEGFP-GABARAP Human GABARAP with N-terminal EGFP fusion (Alemu et al., 2012) 
pDestEGFP-GABARAPL1 Human GABARAP-like1 with N-terminal EGFP 
fusion 
(Alemu et al., 2012) 
pDestEGFP-GABARAPL2 Human GABARAP-like2 with N-terminal EGFP 
fusion 
(Alemu et al., 2012) 
pDest15-LC3A Human LC3A with N-terminal GST fusion (Pankiv et al., 2007) 
pDest15-LC3B Human LC3B with N-terminal GST fusion (Pankiv et al., 2007) 
pDest15-LC3C Human LC3C with N-terminal GST fusion This study 
pDest15-GABARAP Human GABARAP with N-terminal GST fusion (Pankiv et al., 2007) 
pDest15-GABARAPL1 Human GABARAPL1 with N-terminal GST fusion (Pankiv et al., 2007) 
pDest15-GABARAPL2 Human GABARAPL2  with N-terminal GST fusion (Pankiv et al., 2007) 
pSpCas9(BB)-2A-Puro (PX459) 
V2.0 
Cas9 expression vector in human Adgene #62988 
pCS2-nls-zCas9-nls Expression of an optimized Cas9 for genome-
editing in zebrafish 
Addgene #47929 




ZeroBlunt® TOPO PCR Vector In vitro transcription using T7/SP6 Thermo Fisher 
#450245 
pMXs-puro Retroviral vector based on the Moloney murine 
leukemia virus (MMLV). 
Cell Biolabs 
# RTV-012 
pMXs-neo Retroviral vector based on the Moloney murine 
leukemia virus (MMLV). 
Cell Biolabs 
# RTV-011 
pMX-puro mCherry-Parkin Retroviral vector for stably expressing mCherry-
Parkin in cells 
This study 
pMX-neo NIPSNAP1 Retroviral vector for stably expressing Nipsnap1 
in cells 
This study 
pMX-neo NIPSNAP2 Retroviral vector for stably expressing Nipsnap1 
in cells 
This study 
pMX-neo NIPSNAP2del1-24 Retroviral vector for stably expressing Nipsnap1 
in cells 
This study 
pMX-neo NIPSNAP1-EGFP Retroviral vector for stably expressing 
Nipsnap1-egfp in cells 
This study 
pMX-neo NIPSNAP2-EGFP Retroviral vector for stably expressing 
Nipsnap2-egfp in cells 
This study 
pMX-neo NIPSNAP1-MYC Retroviral vector for stably expressing 
Nipsnap2-myc in cells 
This study 
pMX-neo NIPSNAP2-MYC Retroviral vector for stably expressing 




Retroviral vector for stably expressing tandem 
tag mCherry-EGFP OMP25TMmitophagy 
reporter in cells 
This study 
pDest15-NIPSNAP1 Human NIPSNAP1 with N-terminal GST fusion This study 
pDest15-NIPSNAP2 Human NIPSNAP2 with N-terminal GST fusion This study 
pDest15-NIPSNAP21-180 Human NIPSNAP2 deletion mutant (aa1-180) 
with N-terminal GST fusion 
This study 
pDest15-NIPSNAP2181-286 Human NIPSNAP2 deletion mutant (aa181-286) 
with N-terminal GST fusion 
This study 
pDest15-NIPSNAP21-150 Human NIPSNAP2 deletion mutant (aa1-150) 
with N-terminal GST fusion 
This study 
pDest15-NIPSNAP2151-286 Human NIPSNAP2 deletion mutant (aa151-286) 
with N-terminal GST fusion 
This study 
pDest15-NIPSNAP21-220 Human NIPSNAP2 deletion mutant (aa1-220) 
with N-terminal GST fusion 
This study 
pDest15-NIPSNAP2101-286 Human NIPSNAP2 deletion mutant (aa101-286) 
with N-terminal GST fusion 
This study 
pDest15-NDP52 Human NDP52 with N-terminal GST fusion This study 
pDestEGFP-NDP52 Human NDP52 with N-terminal EGFP fusion This study 
pDestEGFP-NDP52 1-414 Human NDP52 deletion mutant (aa 1-414) with 
N-terminal EGFP fusion 
This study 
pDestEGFP-NDP52 L446A Human NDP52 point mutant (L446A) with N-
terminal EGFP fusion 
This study 
pDest15-p62 Human p62 with N-terminal GST fusion (Jain et al., 2010) 
pDest15-Galectin8 Human Galectin8 with N-terminal GST fusion This study 
pDestMYC-NDP52 Human NDP52 with N-terminal MYC tag This study 
pDestMYC-NDP52 1-414 Human NDP52 deletion mutant (aa1-441) with 
N-terminal MYC tag 
This study 
pDestMYC-NDP52 1-382 Human NDP52 deletion mutant (aa1-382) with 
N-terminal MYC tag 
This study 
pDestMYC-NDP52 1-364 Human NDP52 deletion mutant (aa1-364) with 




pDestMYC-NDP52 L446A Human NDP52 point mutant (L446A) with N-
terminal MYC tag 
This study 
pDestMYC-NDP52 C425A Human NDP52 point mutant (C425A) with N-
terminal MYC tag 
This study 
pDestMYC-NDP52 C422A Human NDP52 point mutant (C422A) with N-
terminal MYC tag 
This study 
pDestMYC-NDP52 D439A Human NDP52 point mutant (D439A) with N-
terminal MYC tag 
This study 
pDestMYC-NDP52 F442A Human NDP52 point mutant (F442A) with N-
terminal MYC tag 
This study 
pDestMYC-NDP52 LVV/AAA Human NDP52 point mutant 
(L134,V135,V136/AAA) with N-terminal MYC tag 
This study 
pDestMYC-p62 Human p62 with N-terminal MYC tag (Lamark et al., 2003) 
pDestMYC-TAX1BP1 Human TAX1BP1 with N-terminal MYC tag This study 
pDestMYC-NBR1 Human NBR1 with N-terminal MYC tag (Lamark et al., 2003) 
pDestMYC-NIPSNAP1 Human NIPSNAP1 with N-terminal MYC tag This study 
pDestMYC-NIPSNAP2 Human NIPSNAP2 with N-terminal MYC tag This study 
PDestEYFPN1-NIPSNAP1 Human NIPSNAP1 with C-terminal EYFP fusion This study 
PDestEYFPN1-NIPSNAP2 Human NIPSNAP2 with C-terminal EYFP fusion This study 
pDest3xFLAG-p62 Human p62 with N-terminal 3xFLAG fusion (Jain et al., 2010) 
pcDNA3-sYFP1 N-terminal part of split YFP (Citrine aa 1-158) (Nyfeler et al., 2008)  
pcDNA3-sYFP2 C-terminal part of split YFP (Citrine aa 159-239) (Nyfeler et al., 2008) 
pDestFlpIn-sYFP1-GABARAP N-terminal fusion of Citrine aa 1-158 to 
GABARAP 
This study 










C-terminal fusion of Citrine aa 159-239 to 
NIPSNAP1 
This study 
pNIPSNAP1-EGFP-CIB1 Human NIPSNAP1 with C-terminal fusion of 
EGFP followed by CIB1.  
This study 
CRY2low-tdTomato Fusion of A. thaliana CRY2 aa 1-491 (R489E 
A491D) mutant to tdTomato 
(Duan et al., 2017) 
pcDNA5-FRT-SUMOStar-
NIPSNAP1-EGFP 
FlpIn mammalian expression vector for fusion 
of S.cerevisiae SUMO (R64T/R71E) mutant 
followed by human NIPSNAP1 followed by EGFP 
This study 
pLVX-SUMOstar protease Lentiviral mammalian expression vector for 
S.cerevisiae Ulp1p aa 401-621 
(D451S/T452G/E455S) under control of tet-on 
CMV promoter 
This study 
pEGFP-N3-NIPSNAP2 Human NIPSNAP2 with C-terminal EGFP fusion This study 
pEGFP-N3-NIPSNAP21-19 Human NIPSNAP2 deletion mutant (aa. 1-19) 
with C-terminal EGFP fusion 
This study 
pEGFP-N3-NIPSNAP222-286 Human NIPSNAP2 deletion mutant (aa. 22-286) 
with C-terminal EGFP fusion 
This study 
pEGFP-N3-NIPSNAP259-286 Human NIPSNAP2 deletion mutant (aa. 59-286) 
with C-terminal EGFP fusion 
This study 
pEGFP-N3-NIPSNAP3A25-247 Human NIPSNAP3A deletion mutant (aa. 25-
247) with C-terminal EGFP fusion 
This study 
pEGFP-N3-NIPSNAP3B Human NIPSNAP3B with C-terminal EGFP fusion This study 
pEGFP-N3-NIPSNAP3B25-247 Human NIPSNAP3B deletion mutant (aa. 25-
247) with C-terminal EGFP fusion 
This study 
pLVX-NIPNSPA1-EGFP-3xHA Lentiviral mammalian expression vector for 




pLVX-NIPNSPA1-EGFP-3xFlag Lentiviral mammalian expression vector for 
fusion of NIPSNAP1-EGFP-3xFlag 
This study 
pLVX-PDHA1-EGFP-3xHA Lentiviral mammalian expression vector for 
fusion of PDHA1-EGFP-3xHA 
This study 
pLVX-NIPSNAP1-APEX2 Lentiviral mammalian expression vector for 
fusion of NIPSNAP1-APEX2 
This study 
 
Details on plasmid construction are available upon request. Gateway LR recombination 
reactions were done as described in the Gateway cloning technology instruction manual 
(Invitrogen). Oligonucleotides for PCR and DNA sequencing were obtained from Sigma. All 
plasmid constructs were verified by restriction digestion and/or DNA sequencing (GATC 
Eurofin). 
 
Generation of human knockout cell lines using CRISPR-Cas9 system 
Human NIPSNAP1 and NIPSNAP2 knockout cell lines were generated with the CRISPR-Cas9 
system as described previously (Ran et al., 2013). Two guide RNAs designed for both 
NIPSNAP1 and NIPSNAP2 where annealed and ligated into a BbsI linearized vector (Addgene 
#62988 and #48138) carrying both the Cas9 and puromycin-resistance or EGFP gene, 
respectively. HeLa cells were transfected with the gRNA-containing Cas9 vector using 
Mectafectene Pro (Biontex #T020). For vector with the puromycin resistance gene, HeLa cells 
were treated with 1 µg/mL of puromycin 24 h post transfection for 36 h. Single cells were then 
sorted and plated into 96-well plates. For vector with EGFP gene, EGFP-positive cells were 
sorted by FACS and plated into 96-well plates 48 h post transfection. Single colonies were then 
expanded and screened by immunoblotting. Once knockout were confirmed by 
immunoblotting, genomic DNA were extracted using the Genelute mammalian genomic DNA 
miniprep kit (Sigma #G1N350) and the area of interest amplified by PCR. The amplified region 
was ligated into the PGEM vector (Promega #A3600) and sequenced to identify indels. To 
generate double knockouts, the parental cell lines were transfected sequentially with gRNAs 
for each protein at a time.  Guide RNAs include NIPSNAP1 
(GCGGCTCCAACATGGCTCCG, GCAGCATCTCTGTGACGGCG) NIPSNAP2 
(CGAGGCGCCGAGCAAGATGG, GTCTTCTCGAGATCTGTTGC), NDP52 
(CCTCGTCGAAAGGATTGGAT)  and ATG7 (AGAAGAAGCTGAACGAGTAT). 
 
Generation of stable cell lines and reconstitution of KO cell lines  
Stable cell lines and reconstituted KO cell lines were generated using the pMX vector with 
Puromycin or Neomycin (G418) resistance gene. NIPSNAP1, NIPSNAP2, NIPSNAP1del1-
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24, NIPSNAP1-MYC, NIPSNAP2-MYC, NIPSNAP1-EGFP, NIPSNAP2-EGFP and 
mCherry-EGFP-OMP25TM were PCR amplified and ligated into the pMX vector using 
BamH1 and Not1 sites. These retroviral vectors were packaged in HEK293 cells and resulting 
viral particles were used to transduce both HeLa WT and N1/N2 DKO cells three times for 24h 
each in combination with 8 µg/ml Hexadimethrine bromide (Sigma, #H9268). Protein 
expression was optimized by selection in appropriate antibiotics. 
 
CRISPR/Cas9 genome editing in Zebrafish 
Zebrafish nipsnap1 KO embryos were generated using CRISPR/Cas9 technology as 
described (Jao et al., 2013). Briefly, the web tool “CHOPCHOP” was used to design a set 
of three sgRNA molecules (designated G1-G3), targeting exon 1, 4 and 7 of the 
zebrafish nipsnap1 gene, respectively. A plasmid encoding zebrafish codon-optimized Cas9 
(pCS2-nls-zCas9-nls) was procured from Addgene (Plasmid ID 47929). sgRNA and Cas9 




Synthesized sgRNA integrity was checked on 1% TBE gel. Individual sgRNAs (50–
200 ng/μL) were mixed with capped and poly-adenylated Cas9 mRNA (300 pg/μL) before 
microinjection into the 1 cell stage. Nipsnap1 depletion was validated by immunoblotting.  
 
Genotyping of nipsnap1 mutants 
The zebrafish line carrying the heterozygous nipsnap1sa14357 mutant allele (Zebrafish Mutation 
Project (ZMP)) (Kettleborough et al., 2013) was verified by PCR and sequencing of genomic 
DNA from adult fish fin-clips. DNA was extracted from single embryos or fin clips from 
adult fish using the HotSHOT protocol (Meeker et al., 2007). Purified PCR or gel extracted 
PCR products (Zymoclean Gel DNA Recovery Kit, Zymo Research) were then cloned into 
Blunt End TOPO Vector. Colonies were picked and grown in liquid broth with the 
appropriate antibiotics. Plasmid DNA was isolated, purified and sent for sequencing. 25 μL 
PCR reactions consisted of 0.5 μL Phusion High Fidelity DNA Polymerase (Thermo 
scientific), 5 μL 5X Phusion HF Buffer, 2 μL dNTP (2.5 mM), 0.5 μL forward primer 
(10 μM) (5′TGCATCTGTGGAGATACTCTGGAGG3′), 0.5 μL reverse primer (10 μM) (5′ 
CCCATAAATGATGCACTACATAC3′), 5 μL genomic DNA and 11.5 μL of nuclease free 
water. The Bio-Rad S1000 thermal cycler with the following program was used for 
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amplification: 90 sec at 95 °C, 30 cycles of: 30 sec at 95 °C, 30 sec at 63.1 °C and 30 sec at 
72 °C, followed by 72 °C for 5 min. Sequencing was performed using the reverse M13  
primer. Sequencing traces were analyzed using DNASTAR (Version 14) and ApE (A 




Total RNA was extracted from approximately 50 zebrafish embryos at the indicated 
developmental stages with Trizol (Invitrogen, Inc., USA). The RNA quality was checked by 
260/280 nm absorption using a NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific, 
Inc., USA) and gel analysis. First-strand cDNA was prepared using the SuperScript First-
Strand Synthesis System according to manufacturer’s instructions (Thermo Fisher). 
Amplification was performed with KAPA SYBR FAST qPCR Kit and the CFx96 real-time 
PCR system (Bio-Rad). In brief, reactions were done in 10 μL volumes containing 400 nM of 
each primer, 2.5 μL cDNA (3 ng), 5 μL 2 × KAPA SYBR Green Master Mix Reagent and the 
rest nuclease free water. Reactions were run using the manufacturer's recommended cycling 
parameters of 50 °C for 2 min, 95 °C for 5 min, 40 cycles of 94 °C for 15 s, and 60 °C for 30 s. 
All reactions were performed in triplicate. Relative expression levels were calculated after 
correction for the expression of β-actin as an endogenous reference using the 2−C(t) method. 
Amplification specificity/quality was assessed by analyzing the melting curve. The primer 
sequences used for Nipsnap1 were forward primer 
(5’TCCCTGTGAAGTTGTTGGAAGCTG3’) and reverse primer 
(5’TGCACTGCCTGATCCTGTTCAC3’); for NIPSNAP2 were forward primer 
(5’TGCACTTGTGGAGGTACAGAGG3’) and reverse primer 
(5’TGCGGTACTCCAGAAACTCCTTG3’) and for -actin were forward primer (5’ 
CGAACGACCAACCTAAACCTCTCG3’) and reverse primer (5’ 
ATGCGCCATACAGAGCAGAAGC3’). 
 
Whole-mount in situ hybridization 
Whole-mount in situ hybridizations for nipsnap1 and tyrosine hydroxylase 1 (TH1) were 
performed as previously described (Thisse and Thisse, 2008) using digoxigenin-labelled 
riboprobes. Primer sequences for nipsnap1 sense and antisense probes were; 5’UTR probe: 
forward primer (5’CGGAATCAACAGACAAGGCC3’), reverse primer 
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(5’TACTCAGGCTTGACATTGTG3’), internal probe: forward primer 
(5’ACTCCAATCTGCTCTCCAAG3’), reverse primer 
(5’TCTCTTCTCTGGACTGCAGG3’), 3’UTR probe: forward primer 
(5’CAGATCATATCAGCTACTGC3’), reverse primer 
(5’ACATGCTGTATAGCTCAAGC3’). The TH1 plasmid was a kind gift from Wolfgang 
Driever (Department of Biology I, University of Freiburg). 
Tandem-tag transgenic mitofish generation and imaging 
The pME-EGFP no stop vector from the Tol2 kit was cut with NCoI restriction enzyme and 
then dephosphorylated with calf intestinal phosphatase. This was later phosphorylated with 
T4 polynucleotide kinase and annealed with mitochondrial localization signal (MLS) of 
zebrafish COXVIII (Kim et al., 2008). The oligo sequences used for annealing were forward 
primer 
(5’cATGTCTGGACTTCTGAGGGGACTAGCTCGCGTCCGCGCCGCTCCGGTTCTGC




assembly was used to generate pTol2-CMV-MLS-EGFP-Cherry with linearized pTol2mini 





(5’agatctgggaattcaaggGTGAGCAAGGGCGAGGAG3’) and mCherryRev 
(5’aactagagattcttgtttaagcttgatatccatggACGCCTTAAGATACATTGATGAGTTTG3’). 
Templates for PCR were used from Tol2 Kit. The MLS-EGFP-mCherry was subcloned into 
iTol2 vector using XhoI and AgeI. 35 pg (final concentration) of iTol2 MLS-EGFP-mCherry 
vector and 50 pg (final concentration) of in-vitro transcribed transposase mRNA (in vitro 
transcribed from linearized pCS2FA-transposase vector from the Tol2 kit) was injected into 
the 1 cell stage of control (WT) and Nipsnap1 mutants. Injected embryos were raised to 
adulthood (F0) and out-crossed to wild-type fish to identify transgenic founders.  
Control (WT) tandem-tagged mitofish transgenic founders and Nipsnap1 mutant tandem-
tagged mitofish transgenic founders were incrossed respectively. Resulting respective larvae 
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(F1) were fixed in 4% PFA (pH 7.2) overnight at 3dpf and co-stained with 50ug Hoechst 
reagent for 3-4 h at room temperature. Each larva was mounted on depression slides using 
low melting point agarose. Confocal images were obtained using an Apochromat 40x/1.2 
WC or 60x/1.2 oil DIC objective on an LSM 780 microscope (Zeiss). Red and yellow dots 
were counted manually for each cell and the ratio of red to yellow dots (per cell) were 
interpreted as mitophagy. 
 
Zebrafish rescue experiments 
Full-length wild type zebrafish nipsnap1 was amplified using the oligos: FP – 
ATGATGGCTACCGCACGACCTCTGC and RP – 
TTACTGCAGAGGTGAATGTACCATG. Amplified product was cloned into zero-blunt 
end TOPO vector (ThermoFisher). Capped full-length zebrafish wildtype nipsnap1 mRNA 
was transcribed from linearized zero-blunt TOPO vector using mMessage mMachine 
(Ambion) and later poly(A) tailed using the poly(A) tailing kit (ThermoFisher). 75pg of the 
transcribed mRNA was injected into 1 cell stage of Nipsnap1 mutant tandem-tagged 
transgenic larvae. Larvae at 3dpf were fixed in 4% PFA (pH 7.2) overnight at 3dpf and co-
stained with 50ug Hoechst reagent for 3-4 h at room temperature. Each larva was mounted 
on depression slides using low melting point agarose. Confocal images were obtained using 
an Apochromat 40x/1.2 WC or 60x/1.2 oil DIC objective on an LSM 780 microscope 
(Zeiss). Red and yellow dots were counted manually for each cell and the ratio of red to 
yellow dots (per cell) were interpreted as mitophagy. 
 
Immunoblotting, Immunoprecipitation and Mass Spectrometry 
HeLa cells seeded in either 6-well plates or 6 cm plates were treated as indicated. Cells were 
lysed in 1xSDS (50 mM Tris pH 7.4, 2% SDS, 10% Glycerol) supplemented with 200 mM 
dithiothreitol (DTT, Sigma, #D0632) and heated to 99 °C for 8-10 min. Protein concentration 
was determined by Pierce BCA Protein Assay Kit (Thermofischer Scientific, #23227). 10-40 
µg protein per sample were separated by SDS-PAGE, transferred to nitrocellulose membrane, 
stained with Ponceau S (Sigma, #P3504) and immunoblotted by the indicated antibodies. For 
immunoprecipitation, HeLa cells stably expressing EGFP or EGFP tagged proteins were 
immunoprecipitated by GFP-TRAP (Chromotek, # gta-20) while those expressing MYC-
tagged proteins were immunoprecipitated using MYC-TRAP(Chromotek, # yta-20). HeLa 
cells transiently transfected with 3xFLAG-tagged proteins were immunoprecipitated with anti-
FLAG M2 affinity gel (Sigma, #A2220). Cells were lyses in modified RIPA buffer (50 mM 
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Tris-Cl  pH 7.4, 120 mM NaCl, 1 mM EDTA pH 8.0, 1% NP-40, 0,25% Triton X-100) 
supplemented with cOmplete Mini EDTA-free protease inhibitor cocktail tablets (Roche 
AppliedScience, #11836170001) on ice for 30 min, followed by centrifugation at 10.000 x g 
for 10 min. Supernatants were then incubated with either GFP-TRAP or anti-FLAG M2 affinity 
gel for 2 h and washed five times with RIPA buffer. FLAG-tagged protein were eluted by flag-
peptide in RIPA buffer before boiling in 2x SDS gel loading buffer, while GFP-tagged protein 
were eluted by boiling in 2X SDS gel loading buffer. GFP-tagged proteins were also 
immunoprecipitated using the µMACS GFP Isolation Kit (Miltenyi Biotec) according to the 
instruction manual. For immunoprecipitation of endogenous ALFY,  ALFY+/+ or ALFY-/- 
MEFs were incubated with lysis buffer (150 mM NaCl, 20 mM Hepes pH 7.4, 1% NP40, 
protease inhibitors and phosphatase inhibitors cocktail (Roche)) for 20 min, 4 ˚C, then 
centrifuged for 10 min, 18.000 x g, and supernatant containing 5 mg of protein was incubated 
with 20 µL of anti-ALFY antibody for 2 h, 4˚C, followed by 1 h incubation with 20 µL of 
protein G Dynabeads (ThermoFisher). After incubation, beads were washed four times in 
washing buffer (150 mM NaCl, 20 mM Hepes pH 7.5, 0,1% NP40) and bound proteins were 
eluted by boiling with 0.25% SDS in washing buffer. For immunoblotting of proteins from 
zebrafish, embryos were de-yolked and homogenized in lysis buffer (50 mM Tris-HCl (pH 8), 
150 mM NaCl, 5 mM EDTA, 1% NP-40, 0.5% Sodium deoxycholate, 0.1% SDS, protease 
inhibitor cocktail and (Roche)) 3 d post injections. Protein lysates were separated on Criterion 
TGX Gels (Bio-Rad), transferred to PVDF membrane (Millipore), and incubated overnight at 
4oC with the indicated primary antibodies, followed by 1 h incubation with far-red/green 
fluorophore-conjugated secondary antibodies (LI-COR) and analysis on a LI-COR Odyssey 
Imaging Systems Application. 
Approximately 107 HeLa cells stably transfected with NIPSNA1-EGFP-3xHA, NIPSNAP1-
EGFP-3xFLAG or PDHA1-EGFP-3xHA were washed 2 times with ice-cold PBS, then scraped 
in 1ml of ice-cold KPBS (136mM KCl, 10mM KH2PO4, pH 7.25) and centrifuged at 1000g, 
4˚C for 2 min. The pellet was resuspended in 1ml of KPBS and lysed by 25 plunger strokes in 
homogenizer vessel (VWR, cat. no. 89026-386/89026-398). Lysate was centrifuged at 1000g, 
4˚C for 2 min and supernatant was incubated for 5min at 4˚C with 100μl of anti-HA magnetic 
beads (Thermo Fisher Scientific, cat. no. 88837), then washed 3 times with 1ml KPBS and 
subjected to SDS PAGE and immunoblotting.  
For protein analysis by liquid chromatography-mass spectrometry (LC-MS), the SDS-
PAGE was cut in 12 bands, each band digested with 0.1 µg trypsin (Promega, Madison, WI, 
USA) for 16 h at 37°C, the generated peptides were purified using a ZipTip µ-C18 (Millipore, 
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Billerica, MA, USA), and dried using a Speed Vac concentrator (Concentrator Plus, Eppendorf, 
Hamburg, Germany). The tryptic peptides were dissolved in 10 µL 0.1% formic acid/2% 
acetonitrile and 5 µL analyzed using an Ultimate 3000 nano-HPLC system connected to a LTQ-
Orbitrap XL mass spectrometer (Thermo Fisher Scientific, Bremen, Germany) equipped with 
a nano electrospray ion source. For liquid chromatography separation, an Acclaim PepMap 100 
column (C18, 3 µm beads, 100 Å, 75 μm inner diameter, 50 cm length) (Dionex, Sunnyvale 
CA, USA) was used with a flow rate of 300 nL/min and a solvent gradient of 4-35% B in 47 
min, to 50% B in 10 min and then to 80% B in 1 min. Solvent A was 0.1% formic acid and 
solvent B was 0.1% formic acid/ 90% acetonitrile. The mass spectrometer was operated in the 
data-dependent mode to automatically switch between MS and MS/MS acquisition. Survey full 
scan MS spectra (from m/z 300 to 2,000) were acquired with the resolution R = 60,000 at m/z 
400 after accumulation to a target of 1e6. The maximum allowed ion accumulation times were 
60 ms. The method used allowed sequential isolation of up to the seven most intense ions, 
depending on signal intensity (intensity threshold 1.7e4), for fragmentation using collision 
induced dissociation (CID) at a target value of 10,000 charges and NCE 35 in the linear ion 
trap. Target ions already selected for MS/MS were dynamically excluded for 60 sec. For 
accurate mass measurements, the lock mass option was enabled in MS mode. Data were 
acquired using Xcalibur v2.5.5 and raw files were processed to generate peak list in Mascot 
generic format (*.mgf) using ProteoWizard release version 3.0.331. Database searches were 
performed using Mascot in-house version 2.4.0 to search the SwissProt database (Mouse, 
16,460 proteins) assuming the digestion enzyme trypsin, at maximum one missed cleavage site, 
fragment ion mass tolerance of 0.6 Da, parent ion tolerance of 10 ppm, propionamidylation of 
cysteines, oxidation of methionines, and acetylation of the protein N-terminus as variable 
modifications. Scaffold (version Scaffold_4.3.4, Proteome Software Inc., Portland, OR) was 
used to validate MS/MS based peptide and protein identification. Peptide identifications were 
accepted if they could be established at greater than 95.0% probability by the Peptide Prophet 
with Scaffold delta-mass correction. Protein identifications were accepted if they could be 
established at greater than 99.0% probability and contained at least two identified peptides. 
Protein probabilities were assigned by the Protein Prophet algorithm. 
 
Proximity biotinylation assay 
Approximately 5x106 HeLa cells stably transfected with NIPSNAP1-APEX2 were incubated 
for 30 min with 500μM of biothin tyramide in complete medium, followed by treatment for 
1min with 1mM H2O2 and washing 3 times with 5 ml of quenching solution (10mM sodium 
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azide, 10mM sodium ascorbate, 5mM trolox in PBS). Cells were then scraped in 1ml of 
quenching solution, centrifuged at 3000g for 10min. 4˚C, and pellet was lysed in 2xSDS gel 
loading buffer and subjected to SDS PAGE and immunoblotting with indicated antibodies. 
 
Phos-tag SDS-PAGE analysis 
WT or NIPSNAP1/2 KO cells were plated in 6-well plate and treated 24h after transfection 
with 20μM CCCP for 0.5, 1, 2 and 4h. After treatment cells were lysed in 20mM Tris, pH7,5, 
150mM NaCl, 1% Triton and either left untreated or were treated with lambda protein 
phosphatase (400U phosphatase, 1xPMP buffer, 1mM MnCl2, 30˚C, 30min). Samples were 
resolved on 8% SDS PAGE containing 50μM Phos-tag and 100μM MnCl2, transferred to 
nitrocellulose membrane after washing gel 3x10min in 10mM EDTA and immunostained with 
NIPSNAP1/2 or actin antibodies. 
 
Live Cell and Confocal Immunofluorescence microscopy 
HeLa cells were seeded in 8-well Lab-tek chamber coverglasses (Thermofischer Scientific, # 
155409 &155411) or on coverslips (VWR, #631-0150) and treated as indicated. Cells were 
either examined directly or fixed. Cells were fixed for 10 min at 37 oC in preheated (37 oC) 4% 
PFA, followed by permeabilization in 0.1% Triton  X-100 for 5 min and blocking with 3% goat 
serum for 30 min. Cells were incubated with primary antibodies diluted in PBS for 1 h at room 
temperature and washed five times with PBS, followed by incubation in Alexa Fluor 488-, 
Fluor 555-, or Fluor 647-conjugated secondary antibodies diluted in PBS for 30 min at room 
temperature and washed five times with PBS. During this final wash step, cells were incubated 
with 10 µg/mL DAPI diluted in PBS for 10 min. Confocal images were obtained using an 
Apochromat 40x/1.2 WC or 60x/1.2 oil DIC objective on an LSM 780 microscope (Zeiss) or 
Leica TCS SP5 confocal microscope, 63×1.2W-objective.  
 
Long-lived protein degradation  
To measure the degradation of long-lived proteins by autophagy, cellular proteins were first 
labelled with 0.25 mCi/m L-14C-valine (Perkin Elmer) for 24 h in GIBCO-RPMI 1640 
medium (Invitrogen) containing 10% FBS. The cells were washed and then chased for 16 h in 
nonradioactive Dulbecco’s modified Eagle’s medium (Invitrogen) containing 10% FBS and 10 
mM valine (Sigma), to allow degradation of short-lived proteins. The cells were washed twice 
with EBSS (Invitrogen), and starved or not for 4 h in the presence or absence of 10 mM 3-
methyladenine (Sigma). The medium was then collected and added to 50% Trichloroacetic 
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acid, followed by 2 h incubation at 4 oC and centrifugation to pellet any contaminants. 0.2 M 
potassium hydroxide solution was added to the cells for 2 h before the lysate was collected. 
Ultima Gold LSC cocktail (Perkin Elmer) was added to the medium and cell samples and 
protein degradation was determined by measuring the ratio of radioactivity in the medium 
relative to the total radioactivity detected by a liquid scintillation analyser (Tri-Carb 3100TR, 
Perkin Elmer), counting 3 min per sample. 
 
Recombinant protein expression, in vitro translation and GST-pulldown assay 
GST and GST-fusion proteins were expressed in SoluBL21 Competent Escherichia coli 
(Genlantis, # C700200) and purified by immobilization on Glutathione Sepharose 4 Fast Flow 
beads (GE Healthcare, #17-5132-01). MYC-tagged proteins were in-vitro translated in the 
presence of radioactive 35S-methionine using the TNT T7 Reticulocyte Lysate System 
(Promega, #l4610). For GST-pulldown assay, 10 µL of in-vitro translated protein was pre-
cleared with 10 µL of empty Glutathione sepharose beads in 100 µL of NETN buffer (50 mM 
Tris pH 8.0, 150 mM NaCl, 1 mM EDTA, 0.5% NP-40) supplemented with cOmplete Mini 
EDTA-free protease inhibitor cocktail tablets for 30 min at 4 oC to remove unspecific binding. 
The precleared mixture was then incubated with the immobilized GST-fusion protein and 
incubated for 1-2 h at 4 oC. The beads were washed five times with NETN buffer (500 µL 
NETN buffer followed by centrifugation at 2500 x g for 1 min). After the last wash, 2xSDS 
gel-loading buffer (100 mM Tris pH 7.4, 4% SDS, 20% Glycerol, 0.2% Bromophenol blue and 
200 mM dithiothreitol DTT (Sigma, # D0632) was added and boiled for 10 min followed by 
SDS-PAGE. Gels were stained with Coomassie Brilliant Blue R-250 Dye (ThermoFisher 
Scientific, #20278) for 30 min to visualized the fusion proteins, vacuumed-dried (in Saskia 
HochVakuum combined with BIO-RAD Gel dryer model 583, #1651746) for 30 min. 
Radioactive signals were detected by Fujifilm bioimaging analyzer BAS-5000 (Fujifilm) and 
quantified with ScienceLab ImageGuage software (Fujifilm). 
 
Subcellular fractionation, proteinase K/trypsin treatment and sodium carbonate 
extraction 
Subcellular fractionation was performed with a QProteome mitochondria isolation kit 
(Quiagen) according to the instruction manual. In brief, 107 HeLa cells were resuspended in 1 
mL of lysis buffer, incubated for 10 min at 4 ˚C and centrifuged at 1000 x g for 10 min. The 
supernatant was transferred into a separate tube as cytosolic fraction, while the pellet was 
resuspended in 15 mL of ice-cold disruption buffer, rapidly passed through 21 g needle 10 
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times to disrupt cells and centrifuged at 1000 x g for 10 min, 4 ˚C. The pellet was saved as 
nuclear fraction, while the supernatant was re-centrifuged at 6000 x g for 10 min, 4 ˚C. The 
pellet obtained after centrifugation comprised the mitochondrial fraction, while the supernatant 
contained the microsomal fraction. For PK digestion, mitochondria were resuspended in 
Mitochondrial buffer (MB) (210 mM mannitol, 70 mM sucrose, 10 mM HEPES, 1 mM EDTA, 
pH 7.5) with 50 or 100 µg/mL of PK and incubated 30 min at RT. For trypsin digestion, 
mitochondria were re-suspended in trypsin digestion buffer (10 mM sucrose, 0.1 mM 
EGTA/Tris and 10 mM Tris/HCl, pH 7.4) with 200 µg/mL of trypsin. Both reactions were 
stopped by addition of 5 mM phenylmethylsulfonyl fluoride. For the analysis of integral 
membrane proteins, the mitochondrial fraction was resuspended in MB buffer or MB buffer 
containing freshly prepared 0.1 M Na2CO3 (pH 11.5) and incubated on ice for 30 min. The 
insoluble membrane fraction was centrifuged at 16.000 x g for 15 min.  
 
Mitophagy assay 
Hela cells seeded in 6 cm dishes (or 24 well plates for confocal microscopy) were either treated 
with 10 µM Carbonyl cyanide m-chlorophenyl hydrazine (CCCP) or a combination of 10 µM 
Oligomycin and 4 µM Antimycin A for indicated times. Mitophagy was analyzed by measuring 
the degradation of cytochrome C oxidase subunit II (COXII), a mtDNA encoded inner 
membrane protein, and TIMM23, a nuclear encoded mitochondria inner membrane protein. 
For confocal miscroscopic analyses of mitophagy, mtDNA nucleoids and TIMM23 were 
immunostained with respective antibodies. In addition, we also used a tandem tagged mCherry-
EGFP-OMP25TM mitophagy reporter for visualizing acidified mCherry dots in the lysosome. 
 
In vivo ubiquitination assay 
HeLa WT cells stably expressing mCherry-PARKIN were transfected with NIPSNAP1-MYC, 
NIPSNAP2-MYC, MFN2-MYC and HA-UBIQUITIN. 24h after transfection cells were 
treated with CCCP and MG132 for 3h before harvesting. Cells were collected in lysis buffer 
(2% SDS, 150 mM NaCl, 50 mM Tris, pH 8.0 supplemented with cOmplete Mini EDTA-free 
protease inhibitor cocktail tablets (Roche Applied Science, #11836170001) and N-
ethylmaleimide (Sigma,#E1271)) and heated at 90 oC for 10 min to denature proteins. Lysates 
were diluted 1:10 in dilution buffer (1% TritonX-100, 150 mM NaCl, 50 mM Tris, pH 8.0) and 
myc-tagged proteins immunoprecipitated with MYC-TRAP. Ubiquitination was detected by 




In vitro kinase assay 
In vitro kinase assays with PINK1 were performed with 50 ng of recombinant active PINK1 
kinase (Ubiquigent, #66-0043-050), 1-2 µg of GST-tagged proteins, 60 µM ATP and 2 µCi [γ-
32P] ATP (PerkinElmer, #NEG002A250UC) in 30 µl of kinase buffer (35.5 mMTris pH7.5, 10 
mM MgCl2, 0.5 mM EGTA pH 8.0, 0.1 mM CaCl2 supplemented with cOmplete Mini EDTA-
free protease inhibitor cocktail tablets (Roche AppliedScience, #11836170001) and 
phosphatase inhibitor cocktail (Merck Millipore, #524625)). The reaction was incubated at 30 
oC for 20 min and terminated by addition of 6x SDS-loading buffer. The reaction were then 
analyzed by SDS-PAGE and autoradiography. 
 
Mitochondrial import assay  
Mitochondria were isolated from HeLa or U2OS cells. Approximately 107 cells were pelleted, 
washed in PBS and resuspended in 2 mL of ice-cold isolation buffer (210 mM mannitol, 70 
mM sucrose, 1 mM EGTA, 5 mM HEPES, 0.5% BSA). Cells were sheared with 6 passes 
through Cell Homogenizer (Isobiotech) with 16 µm clearance and centrifuged at 800 x g for 5 
min at 4 ˚C. The supernatant was transferred to a new tube and re-centrifuged at 10.000 x g for 
10 min to pellet the mitochondrial fraction. The pellet was washed two times in washing buffer 
(20 mM HEPES, pH 7.5, 250 mM sucrose, 5 mM MgOAc, 80 mM KOAc, 1 mM DTT) and 
pretreated or not with 10 µM FCCP in mitochondrial import buffer (20 mM HEPES, pH 7.5, 
250 mM sucrose, 5 mM MgOAc, 80 mM KOAc, 10 mM sodium succinate, 2 mM ATP, 0.4 
mM ADP, 1 mM DTT). S35-labeled NIPSNAP1 was co-transcribed/translated in vitro using 
TNT T7 coupled reticulocyte lysate system (Promega) and its product from 100 ng of 
pNIPSNAP1 plasmid was added to isolated mitochondria from 2x106 cells in 30 µL of 
mitochondrial import buffer and reaction was incubated at 37 ˚C for 45 min. Mitochondria 
were then washed three times with washing buffer and treated or not with PK, 25 µg/mL at 
room temperature for 10 min followed by addition of 1 mM PMSF. 
Mitochondrial oxygen consumption rate was measured with the Seahorse XF CellMito 
Stress Test Kit (Agilent Technologies) according to the manufacturer´s instruction.  
 
ROS analysis 
The analysis of reactive oxygen species (ROS) levels in zebrafish was performed as 
described (Mugoni et al., 2014). Briefly, after dissociation into single cells of the respective 
larvae, cells were treated with 10 μM of CellRox (Thermo Fisher Scientific) in Hanks 
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Balanced Salt Solution (HBSS) for 30 min at 28 °C in the dark. Cells were then centrifuged 
for 5 min at 250 x g at 4 °C, the supernatant discarded and the cells washed with HBSS. FACS 
estimations were done on a BD FACS Calibur under standard settings. The voltage for the FL1 
channel was optimized. 1 μM of propidium iodide (PI) (Sigma) was added at room 
temperature for 5 min in the dark prior to FACS.  
Zebrafish locomotor assay  
Larval motility was monitored using the ZebraBox and Viewpoint software (version 
3,10,0,42; Viewpoint Life Sciences, Inc.; Montreal, Quebec, Canada) under infrared light. 
At 6 days post fertilization (dpf), larvae were singly placed in 96-well plates with 300 µL of 
fish water per well, followed by incubation at 28.5 °C on a normal light cycle overnight. All 
experiments were completed in a quiet room at 7 dpf between 10 AM and 2 PM. Larvae 
were allowed to acclimate in the ZebraBox measurement apparatus for 2 h before recording. 
Larvae were then exposed to alternating cycles of light and dark, invisible to the camera, 
every 20 min as described (Emran et al., 2008). Each light transition took approximately 1 
ms. Larval locomotion was tracked with the ViewPoint software. Motility was defined as 
tracks moving less than 10 cm/s, but more than 0.1 cm/s.  
Visualizing Apoptosis by TUNEL Staining 
Control (WT) and nipsnap1 mutant zebrafish larvae were fixed in 4% PFA overnight at 3dpf. 
After a couple of washes with PBST, they were dehydrated in methanol and then rehydrated 
gradually. The respective larvae were permeabilized with 25 µg/ml proteinase K for 30 
minutes at 37°C followed by 20 minutes of 4% PFA fixation at room temperature. The larvae 
were then subjected to TUNEL assay (terminal deoxynucleotidyl transferase-mediated 
deoxyuridine triphosphate nick-end labeling; Thermo Fisher Scientific) according to the 
manufacturer’s instructions. As a positive control, fixed and permeabilized WT larvae were 
incubated with 1 unit of DNase I diluted into 1X DNase I Reaction Buffer (20 mM Tris-
HCl, pH 8.4, 2 mM MgCl2, 50 mM KCl) for 1 hour at room temperature, followed by a 
rinse with deionized water prior to the TUNEL assay. 
Statistics 
Descriptive and analytical statistics were generated in Prism 7.0f (GraphPad Software). 
Statistical significance was analyzed by one-way ANOVA or unpaired Student’s t test and 
data represented as mean ± SD or SEM from three or more independent experiments. All 
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zebrafish experiments were done at least 3-6 times with 20-24 larvae in each experiment. 
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Supplemental Information  
 
Figure S1: NIPSNAP1 and NIPSNAP2 interact with autophagy related proteins 
A-B. Multiple alignment (A) and schematic structure (B) of members of human NIPSNAP-
domain family proteins. MTS - mitochondrial targeting sequence, DABBD1 and DABBD2 - 
dimeric alpha-beta barrel domain 1 and 2.  
C. Overexpressed NIPSNAP1-EGFP can immunoprecipitate endogenous ALFY and p62 from 
WT, ALFY-/-, p62-/- MEFs cells. Extracts from MEFs transiently transfected with EGFP or 
NIPSNAP1-EGFP were used for immunoprecipitation with GFP-trap. Co-immunoprecipitated 
proteins were analyzed by immunoblotting. 
D. Extracts from HeLa cells stably expressing MYC-tagged NIPSNAP1 and NIPSNAP2 were 
used for immunoprecipitation with MYC-trap. Co-immunoprecipitated proteins were analyzed 
by immunoblotting. 
E. GST-tagged p62 and NDP52 proteins immobilized on glutathione-sepharose beads were 
incubated with MYC-tagged full length NIPSNAP1 and NIPSNAP2, in vitro translated in the 
presence of [35S]-methionine. Bound MYC-tagged proteins were detected by autoradiography 
(AR). 
F. GFP, GFP-LC3A, -B or GFP-GABARAP, -L1, -L2 were immunoprecipitated from extracts 
from transiently transfected U2OS cells. Co-immunoprecipitation of endogenous NIPSNAP1 
was visualized by immunoblotting.  
 
Figure S2. NIPSNAP1 and -2 localize both outside and inside of the mitochondria 
A-B. NIPSNAP1 and NIPSNAP2 colocalize with mitochondria markers TOMM20 and DsRed-
Mito. A) HeLa cells transfected with either NIPSNAP1-EGFP or NIPSNAP2-EGFP and 
DsRed-Mito were immunostained for TOMM20 and imaged by fluorescent confocal 
microscopy. B) HeLa cells transiently transfected with EGFP-tagged NIPSNAP1 and 
NIPSNAP2 were stained 24 h after transfection with Mitotracker Red and imaged. Scale bars 
are 10 m. 
C. NIPSNAP1 is mainly an intra-mitochondrial protein. The isolated mitochondrial fraction of 
HeLa cells was incubated in mitochondria import buffer in the presence or absence of 
proteinase K (PK) followed by immunoblotting with the indicated antibodies. 
D. Mitochondrial fractions from HeLa cells were digested with 50 g/ml PK in the presence 
of increasing concentration of digitonin followed by immunoblotting with the indicated 
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antibodies. In the leftmost lanes 25%, 50% and 100% of the mitochondrial fractions were 
loaded to allow direct comparisons of protein amounts. 
E. Full-length NIPSNAP1-mCherry and NIPSNAP1(24-284)-EGFP lacking the N-terminal 
MTS localize to different mitochondrial compartments. U2OS cells were transfected with 
indicated constructs and imaged 24 h later on a Zeiss Elyra S1 super resolution microscope. 
Scale bars are 5 µm. 
F. HeLa cells were transfected for 24 h with the indicated constructs and imaged on Zeiss 
LSM710 laser scanning microscope. Scale bars are 5 µm. 
 
Figure S3. NIPSNAP1 and -2 interact with autophagy-related proteins on the surface of 
mitochondria 
A. HeLa cells transiently transfected with NIPSNAP1-EGFP were treated overnight with 10 
µM CCCP, followed by incubation with 50 nM Mitotracker Red for 30 min. Arrows point to 
NIPSNAP1-EGFP localized around the mitochondria. Scale bar is 5 m (main) and 2 m 
(insert). Region of inset is indicated. 
B. The EGFP tag gets cleaved off from NIPSNAP1 in NIPSNAP1-EGFP construct. HeLa cells 
stably transfected with NIPSNAP1-EGFP under control of tet-inducible CMV promoter were 
untreated or treated with 1 µg/ml of tetracycline for 24-, 48- and 72 h, then lysed and subjected 
to SDS-PAGE and immunoblotting with anti-GFP antibody (upper) or anti-NIPSNAP1 
antibody (lower). * indicates NIPSNAP1-EGFP degradation product. 
C. Overexpressed NIPSNAP1-3xFLAG co-localizes with TIMM23 and shows two different 
phenotypes of mitochondrial distribution; - reticular (upper panel) and vesicular (lower panel). 
U2OS cells were transiently transfected with NIPSNAP1-3xFLAG and stained with anti-
FLAG- and anti-TIMM23 antibodies. Scale bar is 10 m. 
D-E. HeLa cells stably transfected with SUMOstar-NIPSNAP1-EGFP under control of a 
constitutive CMV promoter and SUMOstar protease under control of a Tet-ON regulated CMV 
promoter were untreated (D, upper panel) or treated with 1 µg/ml of doxycyclin for 10 h to 
induce SUMOstar protease expression (D, lower panel). Scale bar is 10 m. (E) The SUMOstar 
tag is cleaved from SUMOstar-NIPSNAP1-EGFP in the presence of SUMOstar protease. Cell 
lysate from HeLa cells stably transfected with SUMOstar-NIPSNAP1-EGFP under control of 
a constitutive CMV promoter and SUMOstar protease under control of a Tet-ON regulated 
CMV promoter were untreated or treated with 1 μg/ml of doxycycline for 24h, lysed and 
subjected to SDS-PAGE and immunobloting with anti-GFP antibody.*- unspecific band. 
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F. NIPSNAP2-EGFP, or EGFP only, was immunoprecipitated from extracts of stably 
transfected HEK293 cells using GFP-Trap. Immunoblotting for endogenous p62 revealed an 
increase in co-immunoprecipitation following treatment with 10 µM CCCP or exposure to 1% 
hypoxia for 6 h, respectively. 
G. HeLa cells stably transfected with NIPSNAP1-APEX2 were treated with 20 μM CCCP for 
the indicated time periods or left untreated. The last 30 min before lysis/cell fixation cells were 
incubated with 500 μM biotinyl tyramide followed by 1 min treatment with 1 mM H2O2. Cells 
were then either fixed and stained with Alexa Fluor 488-streptavidin (upper) or lysed, 
precipitated with streptavidin-conjugated magnetic beads and immunostained with the 
indicated antibodies (lower). 
H. U2OS cells were transiently transfected with NIPSNAP1-sYFP1 and NIPSNAP1-sYFP2 
(left panel) or with sYFP1-GABARAP and sYFP2-GABARAP (right panel), then treated with 
10 µM CCCP for 6 h and stained with Mitotracker Red before confocal imaging. Control 
experiment for bimolecular complementation is shown in Figure 4F. Scale bars are 10 m. 
 
Figure S4.  NIPSNAP1 and -2 have a redundant function in PARKIN-dependent 
mitophagy 
A. HeLa cells stably expressing EGFP-PARKIN were transfected with either siRNA against 
NIPSNAP1, NIPSNAP2, ATG7 or a non-targeting control and analyzed by immunoblotting 
with the indicated antibodies 48 h post-transfection. 
B. HeLa EGFP-PARKIN cells were transfected as in (A), then treated or not with 10 µM CCCP 
for 12 or 24 h and subjected to immunoblotting with the indicated antibodies. 
C. Densitometric analyses of the TIMM23/ACTIN ratio (B). Values are mean ± s.d. from three 
independent experiments. ***p ˂ 0.001, NS: not significant, one-way ANOVA. 
D. Representative confocal images of HeLa EGFP-PARKIN cells transfected as in (A), treated 
with CCCP for 12 or 24 h followed by staining with anti-TIMM23 antibody and DAPI (4′,6-
diamidino-2-phenylindole). Scale bars are 20 μm. 
E. Quantification of TIMM23 staining after 12 h and 24 h of CCCP treatment from more than 
85 cells per sample. Similar results were obtained in three independent experiments. ***p ˂ 
0.001, NS: not significant, one-way ANOVA. 
F. HeLa EGFP-PARKIN cells were transfected as in (A), then treated or not with OA for 12 
or 24 h and subjected to immunoblotting with the indicated antibodies. 
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G. Densitometric analyses of the TIMM23/actin ratio in (F). Values are mean ± s.d. from three 
independent experiments. ***p ˂ 0.001, NS: not significant, one-way ANOVA. 
H. HeLa cells stably expressing EGFP-PARKIN were transfected with either non-targeting 
siRNA or siRNA against NIPSNAP1, NIPSNAP2 or ATG7, then treated or not with CCCP for 
the indicated time and subjected to immunoblotting. 
I. HeLa cells were transfected with control siRNA or two different siRNAs against NIPSNAP1 
and one siRNA against NIPSNAP2 and immunoblotted after 48 h. 
J. NIPSNAP1, NIPSNAP2 and ATG7 knockout HeLa cells were confirmed by 
immunoblotting. 
K-L. WT, NIPSNAP1, NIPSNAP2 and ATG7 knockout HeLa cells with or without mCherry-
PARKIN were treated with OA for 12 or 24 h and immunoblotted with the indicated antibodies. 
Two different clones for each NIPSNAP KO cell lines are shown. 
 
Figure S5. NIPSNAP1 and -2 are not required for DFP-induced mitophagy or respiration  
A. WT, NIPSNAP1 and NIPSNAP2 double knockout (N1/N2 DKO) and ATG7 KO HeLa cells 
with or without mCherry-PARKIN were treated with CCCP for 12 or 24 h and immunoblotted 
with indicated antibodies. 
B. WT, N1/N2 DKO and ATG7 KO HeLa cells stably expressing mCherry-EGFP-OMP25TM 
treated or not with CCCP for 6 h were analyzed by confocal microscopy. Scale bars are 10 m. 
C. HeLa mCherry-PARKIN WT, NIPSNAP1 and NIPSNAP2 double knockout (N1/N2 DKO) 
cells and DKO cells rescued with either NIPSNAP1 or NIPSNAP2 were treated with CCCP 
for the indicated time and immunoblotted with the indicated antibodies. 
D-F. NIPSNAP1 or NIPSNAP2 knock down does not affect mitophagy in the absence of 
PARKIN. U2OS cells stably transfected with NIPSNAP (1-53)-EGFP-mCherry were depleted 
for NIPSNAP1, NIPSNAP2 or ULK1 with siRNA transfection and then treated with CCCP, 
hypoxia or DFP. Cells containing more than 5 “red-only” dots were counted as mitophagy 
competent. Representative imaged from experiment are presented on left panel (D), lower-right 
panel present immunoblotting of lysed cells from experiment (E) with quantification presented 
on upper-right panel based on more than 200 cells/condition from 18 separate fields of view, 
from two independent experiments with error bars representing variation between experiment 
averages (F). 
G. Knock down of NIPSNAP1 and NIPSNAP2 does not affect mitochondrial oxygen 
consumption. Mitochondrial stress on U2OS cells, transfected with control siRNA or siRNA 
5 
 
targeting NIPSNAP1 and NIPSNAP2 individually or in combination, was analyzed using 
Seahorse XFe96 Extracellular Flux Analyzer. Cells were treated with 0.5 µM Oligomycin 
(Injection1), 400 nM FCCP (Injection2) and 0.5 µM Rotenone/Antimycin A (Injection3) to test 
mitochondrial metabolism. The graph shows one representative out of two independent 
experiments and the error bars represents the variation between technical replicates.  
H. Knock down of NIPSNAP1 and NIPSNAP2 does not affect long-lived protein degradation. 
The degradation of long-lived proteins in HeLa cells transfected with control siRNA or siRNA 
targeting both NIPSNAP1 and NIPSNAP2 was quantified as the release of 14C-valine after 4 h 
starvation in the absence or presence of 3-methyladenine (3MA) (mean±s.e.m., n=3). 
I.   No significant difference in the rate of long-lived protein degradation in control and 
NIPSNAP1 and -2 DKO cells overexpressing PARKIN in the absence or presence of CCCP. 
WT and NIPSNAP1 and -2 DKO cells were incubated in media containing 14C-L-Valine for 
24 h for long-lived protein degradation. The cells were then chased for 16 h in media with L-
Valine. Cells were treated with CCCP and/or BafA1 for 4 h. The supernatant was collected and 
TCA added to precipitate and separate proteins from free 14C.  The cells in the dish were lysed 
with 0.2 M KOH. The radioactivity in the supernatant fraction and the cell fraction was then 
measured on a scintillation counter. The rate of long-lived protein degradation is represented 
as amount of radioactivity in the supernatant divided by the total radioactivity, divided by the 
duration of treatment. The graph shows the average of two independent experiments each 
performed in triplicates and error bars indicate standard deviation. 
J. HeLa cells were transfected with mCherry-PARKIN together with EGFP or NIPSNAP1-
EGFP, followed by GFP-immunoprecipitation and immunoblotting with the indicated 
antibodies.  
 
Figure S6. NIPSNAP1 and -2 are not required for macroautophagy and are not modified 
by PINK1 or PARKIN. 
A. NIPSNAP1-EGFP and NIPSNAP2-EGFP were stably expressed in HeLa mCherry-
PARKIN cells and treated with either CCCP or OA for 24 h followed by immunoblotting with 
indicated antibodies 
B. Densitometric analysis of COXII levels from (A). Values are mean ± s.d. from three 
independent experiments. *p ˂ 0.01, NS Not significant, one-way ANOVA. 
C. NIPSNAP1 and -2 DKO does not affect basal macroautophagy. HeLa WT, N1/N2 DKO 




D. NIPSNAP1 and -2 DKO does not affect starvation induced macroautophagy. WT, N1/N2 
DKO and ATG7 KO cells were treated with Hanks balanced salt solution (HBSS) alone or in 
combination with BafA1 for 3 h and immunoblotted with indicated antibodies. 
E. WT, N1/N2 DKO cells and N1/N2 DKO cells rescued with untagged NIPSNAP2 or 
NIPSNAP2 del1-24 and stably expressing mCherry-PARKIN were treated with CCCP for 12 
or 24 h and immunoblotted with the indicated antibodies. 
F. NIPSNAP1/2 are phosphoproteins. HeLa cells stably expressing mCherry-PARKIN were 
treated with 20 μM CCCP for indicated time periods or left untreated, lysed and subjected to 
Mn2+-Phos-tag SDS-PAGE and immunoblotting with indicated antibodies.  
G. PINK1 does not phosphorylate NIPSNAP1/2. In vitro phosphorylation was performed with 
recombinant PINK1 incubated with GST and indicated GST-tagged proteins in the presence of 
60 μM unlabeled ATP and 2 μCi [32P]-ATP. The reactions were analyzed by autoradiography. 
H. WT or N1/N2 DKO HeLa cells stably transfected with mCherry-PARKIN were treated with 
20 μM CCCP for indicated periods of time, lysed and immunoprecipitated with anti-ubiquitin 
(upper) or anti-NIPSNAP2 (lower) antibody and subjected to SDS PAGE/immunostaining with 
indicated antibodies. 
I. NIPSNAP1 and -2 are not ubiquitinated by PARKIN. In vitro ubiquitination assay were 
performed by transient over-expression of MYC-tagged proteins and HA-tagged ubiquitin in 
HeLa mCherry-PARKIN cells. Cells were treated with CCCP and MYC-tagged proteins 
immunoprecipitated with MYC-TRAP followed by immunoblotting with indicated antibodies. 
Asterisks indicate unspecific bands. 
J-K. Mapping of binding sites of p62 and NDP52 on NIPSNAP1 and NIPSNAP2. J. MYC-
tagged p62 and NDP52 were in vitro translated and used in GST pulldown with GST-tagged 
NIPSNAP2 WT and indicated mutants. K. GST-pulldown assay between in vitro translated 
MYC-tagged NIPSNAP1 WT and mutants with GST-tagged p62 and NDP52. Bound myc-
tagged proteins were detected by autoradiography (AR) and the GST proteins by Coomassie 
Brilliant Blue (CBB). 
L. NIPSNAP1 and -2 interact with the zinc finger-2 (ZF2) domain of NDP25. MYC-tagged 
NIPSNAP1 and -2 were in vitro-translated in the presence of [35S]-methionine and their 
interaction with GST-tagged NDP52 and mutants analyzed by autoradiography. 
M. Confirmation of NDP52 knockout in NDP52 KO HeLa cells by immunoblotting. 
 




A-B. Clustal W alignment of Nipsnap1 (A) and Nipsnap2/Gbas (B) amino acid sequences from 
zebrafish (Danio rerio, accession NP_571108 and NP_571109, respectively) with the 
respective human and mouse sequences. Identical residues are boxed in black. The N-terminal 
23 amino acids of zebrafish Nipsnap1 are predicted to act as a MLS (MitoProt II) (red line). 
The DABB1 domain (green boxed region) and the DABB2/Nipsnap domain (blue boxed region) 
are highly conserved with amino acid identities of ≥90%, indicating a similar function across 
species. 
C. Temporal expression pattern of nipsnap1 and nipsnap2. The graph shows the fold change 
in transcript relative to -actin in whole zebrafish embryos from 1 cell to 7 dpf.  
D. Spatial expression pattern of nipsnap2 across the different development stages of zebrafish 
as demonstrated by whole-mount in situ hybridization at the indicated stages. All embryos were 
in lateral view. Scale bar - 200 µm.  
E. Immunblotting for Nipsnap1 and Nipsnap2 in lysates from different tissues of adult 
zebrafish.  
F. Manipulations of the zf nipsnap1 gene. Schematic description of the exon (black boxes) and 
intron (black lines) structure of the nipsnap1 gene. Scissors indicate the sgRNA1 used to target 
the 1st exon to make the nipsnap1 KO embryos (nipsnap-/-). A chromatogram showing the 
genotype of then nipsnap1sa14357 mutant allele (nipsnap1 mutant) is shown. The change in allele 
from T to A has been highlighted.  
G. Representative immunoblotting images of Nipsnap1 and β-tubulin on whole embryo lysates 
of nipsnap1 mutant, rescue and WT embryos at 3dpf. β-tubulin serves as the loading control.  
H. Representative FACS plot showing oxidative stress in Controls (WT), nipsnap1-/- embryos 
and nipsnap1 mutant embryos at 3 dpf using the CellROX reagent. H2O2 was added to the 
water for 1 h as a positive control.  
I. Quantification of the Th1 signal intensities from blots in (Fig 7G) normalized to WT signal 
intensity. 
J. Qualitative analysis of the plate used for zebrabox experiments with L-DOPA added. Top 6 
wells contain WT larvae, bottom six wells contain nipsnap1mutant larvae. Plate was used for 
swimming assay earlier and then kept overnight to see oxidation of L-Dopa by visualizing the 
change in color. 
All error bars indicate Standard Error of Mean (S.E.M). *p < 0.05, **p < 0.005, ***p < 0.0005, 
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NIPSNAP1-MYC -  +  +  +  +   -   -   -  -   -   -   -   - 
NIPSNAP2-MYC -  -   -   -   -   +  +  +  +  -   -   -   -
MFN2-MYC -  -   -   -   -   -   -   -   -  +  +   +  +
mCHERRY-PARKIN -  -   -   +  +  -   -   +  +  -   -   +  +
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